Browse by UCL Departments and Centres
![[up]](/style/images/multi_up.png)
Up a levelGroup by: Author | Type
Number of items: 318.
A
Abdallah, S;
Benetos, E;
Gold, NE;
Hargreaves, S;
Weyde, T;
Wolff, D;
(2016)
Digital Music Lab: A Framework for Analysing Big Music Data.
In:
Proceedings of the 2016 24th European Signal Processing Conference (EUSIPCO).
(pp. pp. 1118-1122).
IEEE: Budapest, Hungary.
|
 |
|
Abdel-Gadir, A;
Berber, R;
Porter, JB;
Quinn, PD;
Suri, D;
Kellman, P;
Hart, AJ;
... Skinner, JA; + view all
(2016)
Detection of metallic cobalt and chromium liver deposition following failed hip replacement using T2* and R2 magnetic resonance.
Journal of Cardiovascular Magnetic Resonance
, 18
, Article 29. 10.1186/s12968-016-0248-z.
|
|
|
Abdel-Gadir, A;
Vorasettakarnkij, Y;
Ngamkasem, H;
Nordin, S;
Ako, EA;
Tumkosit, M;
Sucharitchan, P;
... Moon, JC; + view all
(2016)
Ultrafast Magnetic Resonance Imaging for Iron Quantification in Thalassemia Participants in the Developing World The TIC-TOC Study (Thailand and UK International Collaboration in Thalassaemia Optimising Ultrafast CMR).
Circulation
, 134
(5)
pp. 432-434.
10.1161/CIRCULATIONAHA.116.022803.
|
|
|
Abdollah, MRA;
(2016)
Developing superparamagnetic iron oxide nanoparticles as targeted cancer nanomedicine.
Doctoral thesis , UCL (University College London).
|
|
Ako, EOI;
Barber, N;
Kowalik, G;
Steeden, JA;
Porter, J;
Walker, J;
Muthurangu, V;
(2016)
MR-Augmented Cardiopulmonary Exercise Testing - a proof of concept in Sickle Cell Disease.
Presented at: Society for Cardiovascular Magnetic Resonance: 19th Annual SCMR Scientific Sessions, Los Angeles, California, USA.
|
|
|
Alliouachene, S;
Bilanges, B;
Chaussade, C;
Pearce, W;
Foukas, LC;
Scudamore, CL;
Moniz, LS;
(2016)
Inactivation of class II PI3K-C2α induces leptin resistance, age-dependent insulin resistance and obesity in male mice.
Diabetologia
, 59
(7)
pp. 1503-1512.
10.1007/s00125-016-3963-y.
|
|
Alzoubi, S;
Brody, L;
Rahman, S;
Mahul-Mellier, AL;
Mercado, N;
Ito, K;
El-Bahrawy, M;
... Hajji, N; + view all
(2016)
Synergy between histone deacetylase inhibitors and DNA-damaging agents is mediated by histone deacetylase 2 in colorectal cancer.
Oncotarget
, 7
(28)
pp. 44505-44521.
10.18632/oncotarget.9887.
|
|
|
Amelina, H;
Moiseeva, V;
Collopy, LC;
Pearson, SR;
Armstrong, CA;
Tomita, K;
(2016)
Sequential and counter-selectable cassettes for fission yeast.
BMC Biotechnology
, 16
, Article 76. 10.1186/s12896-016-0307-4.
|
|
|
Aneke, JC;
Huntley, N;
Porter, J;
Eleftheriou, P;
(2016)
Effect of automated red cell exchanges on oxygen saturation on-air, blood parameters and length of hospitalization in sickle cell disease patients with acute chest syndrome.
Nigerian Medical Journal
, 57
(3)
pp. 190-193.
10.4103/0300-1652.184073.
|
|
|
Ang, JE;
Pandher, R;
Ang, JC;
Asad, YJ;
Henley, A;
Valenti, M;
Box, G;
... Raynaud, FI; + view all
(2016)
Plasma metabolomic changes following PI3K inhibition as pharmacodynamic biomarkers: preclinical discovery to Phase I trial evaluation.
Molecular Cancer Therapeutics
, 15
(6)
pp. 1412-1424.
10.1158/1535-7163.MCT-15-0815.
|
|
Anguita, E;
Gupta, R;
Olariu, V;
Valk, PJ;
Peterson, C;
Delwel, R;
Enver, T;
(2016)
A somatic mutation of GFI1B identified in leukemia alters cell fate via a SPI1 (PU.1) centered genetic regulatory network.
Developmental Biology
, 411
(2)
pp. 277-286.
10.1016/j.ydbio.2016.02.002.
|
|
|
Anjos-Afonso, F;
Loizou, JI;
Bradburn, A;
Kanu, N;
Purewal, S;
Da Costa, C;
Bonnet, D;
(2016)
Perturbed hematopoiesis in mice lacking ATMIN.
Blood
, 128
(16)
pp. 2017-2021.
10.1182/blood-2015-09-672980.
|
|
|
Anthias, CN;
(2016)
Related haematopoietic progenitor cell donor care: the influence of current guidance, and pathways to improvement.
Doctoral thesis , UCL (University College London).
|
|
|
Arachchillage, DRJ;
Mackie, IJ;
Efthymiou, M;
Chitolie, A;
Hunt, BJ;
Isenberg, DA;
Khamashta, M;
... Cohen, H; + view all
(2016)
Rivaroxaban limits complement activation compared with warfarin in antiphospholipid syndrome patients with venous thromboembolism.
Journal of Thrombosis and Haemostasis
, 14
(11)
pp. 2177-2186.
10.1111/jth.13475.
|
|
|
Aref, S;
Bailey, K;
Fielding, A;
(2016)
Measles to the Rescue: A Review of Oncolytic Measles Virus.
Viruses
, 8
(10)
10.3390/v8100294.
|
|
|
Arends, M;
Wanner, C;
Hughes, D;
Mehta, A;
Oder, D;
Watkinson, OT;
Elliott, PM;
... Hollak, CE; + view all
(2016)
Characterization of Classical and Nonclassical Fabry Disease: A Multicenter Study.
Journal of the American Society of Nephrology
, 28
(5)
pp. 1631-1641.
10.1681/ASN.2016090964.
|
|
|
Astle, WJ;
Elding, H;
Jiang, T;
Allen, D;
Ruklisa, D;
Mann, AL;
Mead, D;
... Soranzo, N; + view all
(2016)
The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease.
Cell
, 167
(5)
pp. 1415-1429.
10.1016/j.cell.2016.10.042.
|
|
Attard, G;
Antonarakis, ES;
(2016)
Prostate cancer: AR aberrations and resistance to abiraterone or enzalutamide.
Nature Reviews Urology
, 13
(12)
pp. 697-698.
10.1038/nrurol.2016.212.
|
|
B
|
Bachanova, V;
Weisdorf, DJ;
Wang, T;
Marsh, SG;
Trachtenberg, E;
Haagenson, MD;
Spellman, SR;
... Cooley, SA; + view all
(2016)
Donor KIR B Genotype Improves Progression-Free Survival of Non-Hodgkin Lymphoma Patients Receiving Unrelated Donor Transplantation.
Biology of Blood and Marrow Transplantation
, 22
(9)
pp. 1602-1607.
10.1016/j.bbmt.2016.05.016.
|
|
Bangham, M;
Goldstein, R;
Walton, H;
Ledermann, JA;
(2016)
Olaparib treatment for BRCA-mutant ovarian cancer with leptomeningeal disease.
Gynecologic Oncology Reports
, 18
pp. 22-24.
10.1016/j.gore.2016.10.004.
|
|
|
Bartlett, TE;
Chindera, K;
McDermott, J;
Breeze, CE;
Cooke, WR;
Jones, A;
Reisel, D;
... Widschwendter, M; + view all
(2016)
Epigenetic reprogramming of fallopian tube fimbriae in BRCA mutation carriers defines early ovarian cancer evolution.
Nature Communications
, 7
, Article ARTN 116. 10.1038/ncomms11620.
|
|
|
Beeken, RJ;
Croker, H;
Heinrich, M;
Smith, L;
Williams, K;
Hackshaw, A;
Hines, J;
... Fisher, A; + view all
(2016)
Study protocol for a randomised controlled trial of brief, habit-based, lifestyle advice for cancer survivors: exploring behavioural outcomes for the Advancing Survivorship Cancer Outcomes Trial (ASCOT).
BMJ Open
, 6
(11)
, Article e011646. 10.1136/bmjopen-2016-011646.
|
|
|
Behjati, S;
Gundem, G;
Wedge, DC;
Roberts, ND;
Tarpey, PS;
Cooke, SL;
Van Loo, P;
... Campbell, PJ; + view all
(2016)
Mutational signatures of ionizing radiation in second malignancies.
Nature Communications
, 7
, Article 12605. 10.1038/ncomms12605.
|
|
Bell, LC;
Pollara, G;
Pascoe, M;
Tomlinson, GS;
Lehloenya, RJ;
Roe, J;
Meldau, R;
... Noursadeghi, M; + view all
(2016)
In Vivo Molecular Dissection of the Effects of HIV-1 in Active Tuberculosis.
PLOS Pathogens
, 12
(3)
, Article e1005469. 10.1371/journal.ppat.1005469.
|
|
Beltran, M;
Yates, CM;
Skalska, L;
Dawson, M;
Reis, FP;
Viiri, K;
Fisher, CL;
... Jenner, RG; + view all
(2016)
The interaction of PRC2 with RNA or chromatin is mutually antagonistic.
Genome Research
, 26
(7)
pp. 896-907.
10.1101/gr.197632.115.
|
|
Bendell, JC;
Patel, MR;
Yoshida, K;
Seraj, J;
Weaver, R;
Lemech, C;
Todaro, TG;
... Arkenau, H-T; + view all
(2016)
Phase 1 study of cardiac safety of TAS-102 in patients with advanced solid tumors.
Cancer Chemother Pharmacol
, 77
(6)
pp. 1275-1283.
10.1007/s00280-016-3031-9.
|
|
|
Benson, AB;
Kiss, I;
Bridgewater, J;
Eskens, FALM;
Sasse, C;
Vossen, S;
Chen, J;
... Krivoshik, A; + view all
(2016)
BATON-CRC: A Phase II Randomized Trial Comparing Tivozanib Plus mFOLFOX6 with Bevacizumab Plus mFOLFOX6 in Stage IV Metastatic Colorectal Cancer.
Clinical Cancer Research
, 22
(20)
pp. 5058-5067.
10.1158/1078-0432.CCR-15-3117.
|
|
Bentham, RB;
(2016)
A bioinfomatic analysis of the role of mitochondrial biogenesis in human pathologies.
Doctoral thesis , UCL (University College London).
|
|
Bentzen, AK;
Marquard, AM;
Lyngaa, R;
Saini, SK;
Ramskov, S;
Donia, M;
Such, L;
... Hadrup, SR; + view all
(2016)
Large-scale detection of antigen-specific T cells using peptide-MHC-I multimers labeled with DNA barcodes.
Nature Biotechnology
, 34
(10)
pp. 1037-1045.
10.1038/nbt.3662.
|
|
|
Bergerhoff, KF;
(2016)
Cellular and molecular events controlling acquisition of cytotoxic activity by melanoma-reactive CD4⁺ T cells in vivo.
Doctoral thesis , UCL (University College London).
|
|
Bhatnagar, G;
Makanyanga, J;
Ganeshan, B;
Groves, A;
Rodriguez-Justo, M;
Halligan, S;
Taylor, SA;
(2016)
MRI texture analysis parameters of contrast-enhanced T1-weighted images of Crohn's disease differ according to the presence or absence of histological markers of hypoxia and angiogenesis.
Abdominal Radiology
, 41
(7)
pp. 1261-1269.
10.1007/s00261-016-0657-3.
|
|
|
Blandford, A;
Furniss, D;
Lyons, I;
Chumbley, G;
Iacovides, I;
Wei, L;
Cox, A;
... Franklin, B; + view all
(2016)
Exploring the Current Landscape of Intravenous Infusion Practices and Errors (ECLIPSE): protocol for a mixed-methods observational study.
BMJ Open
, 6
, Article e009777. 10.1136/bmjopen-2015-009777.
|
|
|
Bochtler, W;
Gragert, L;
Patel, ZI;
Robinson, J;
Steiner, D;
Hofmann, JA;
Pingel, J;
... Mueller, CR; + view all
(2016)
A comparative reference study for the validation of HLA-matching algorithms in the search for allogeneic hematopoietic stem cell donors and cord blood units.
HLA
, 87
(6)
pp. 439-448.
10.1111/tan.12817.
|
|
|
Bock, C;
Halbritter, F;
Carmona, FJ;
Tierling, S;
Datlinger, P;
Assenov, Y;
Berdasco, M;
... Zhang, K; + view all
(2016)
Quantitative comparison of DNA methylation assays for biomarker development and clinical applications.
NATURE BIOTECHNOLOGY
, 34
(7)
pp. 726-737.
10.1038/nbt.3605.
|
|
|
Braso-Maristany, F;
Filosto, S;
Catchpole, S;
Marlow, R;
Quist, J;
Francesch-Domenech, E;
Plumb, DA;
... Tutt, AN; + view all
(2016)
PIM1 kinase regulates cell death, tumor growth and chemotherapy response in triple-negative breast cancer.
Nature Medicine
, 22
(11)
pp. 1303-1313.
10.1038/nm.4198.
|
|
|
Breeze, CE;
Paul, DS;
van Dongen, J;
Butcher, LM;
Ambrose, JC;
Barrett, JE;
Lowe, R;
... Beck, S; + view all
(2016)
eFORGE: A Tool for Identifying Cell Type-Specific Signal in Epigenomic Data.
Cell Reports
, 17
(8)
pp. 2137-2150.
10.1016/j.celrep.2016.10.059.
|
|
|
Bridgewater, J;
Lopes, A;
Beare, S;
Duggan, M;
Lee, D;
Ricamara, M;
McEntee, D;
... Valle, JW; + view all
(2016)
A phase 1b study of Selumetinib in combination with Cisplatin and Gemcitabine in advanced or metastatic biliary tract cancer: the ABC-04 study.
BMC Cancer
, 16
(1)
p. 153.
10.1186/s12885-016-2174-8.
|
|
|
Brimble, MA;
Zhou, J;
Morton, C;
Meagher, M;
Nathwani, AC;
Gray, JT;
Davidoff, AM;
(2016)
AAV Preparations Contain Contamination from DNA Sequences in Production Plasmids Directly Outside of the ITRs.
Presented at: 19th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT), Washington DC, USA.
|
|
|
Brown, N;
McBain, C;
Nash, S;
Hopkins, K;
Sanghera, P;
Saran, F;
Phillips, M;
... Mulholland, P; + view all
(2016)
Multi-Center Randomized Phase II Study Comparing Cediranib plus Gefitinib with Cediranib plus Placebo in Subjects with Recurrent/Progressive Glioblastoma.
PLoS ONE
, 11
(5)
10.1371/journal.pone.0156369.
|
|
Brown, S;
Hinsley, S;
Ballesteros, M;
Bourne, S;
McGarry, P;
Sherratt, D;
Flanagan, L;
... Myeloma UK Clinical Trials Network, .; + view all
(2016)
The MUK five protocol: a phase II randomised, controlled, parallel group, multi-centre trial of carfilzomib, cyclophosphamide and dexamethasone (CCD) vs. cyclophosphamide, bortezomib (Velcade) and dexamethasone (CVD) for first relapse and primary refractory multiple myeloma.
BMC Hematology
, 16
, Article 14. 10.1186/s12878-016-0053-9.
|
|
Burrows, N;
Cane, G;
Robson, M;
Gaude, E;
J Howat, W;
Szlosarek, PW;
Pedley, RB;
... Maxwell, PH; + view all
(2016)
Hypoxia-induced nitric oxide production and tumour perfusion is inhibited by pegylated arginine deiminase (ADI-PEG20).
Scientific Reports
, 6
, Article 22950. 10.1038/srep22950.
|
|
|
Butcher, LM;
Ito, M;
Brimpari, M;
Morris, TJ;
Soares, FA;
Ährlund-Richter, L;
Carey, N;
... Beck, S; + view all
(2016)
Non-CG DNA methylation is a biomarker for assessing endodermal differentiation capacity in pluripotent stem cells.
Nature Communications
, 7
, Article 10458. 10.1038/ncomms10458.
|
|
C
|
Campbell, J;
Ryan, CJ;
Brough, R;
Bajrami, I;
Pemberton, HN;
Chong, IY;
Costa-Cabral, S;
... Lord, CJ; + view all
(2016)
Large-Scale Profiling of Kinase Dependencies in Cancer Cell Lines.
Cell Reports
, 14
(10)
pp. 2490-2501.
10.1016/j.celrep.2016.02.023.
|
|
Cappellini, MD;
Cassiman, D;
Marinakis, T;
Rosenbaum, H;
Bauduer, F;
Bjerrum, OW;
Fraga, C;
... Villarrubia, J; + view all
(2016)
Investigating rare haematological disorders - A celebration of 10 years of the Sherlock Holmes symposia.
European Oncology and Haematology
, 12
(1)
pp. 55-61.
10.17925/EOH.2016.12.01.55.
|
|
|
Carter, T;
Mulholland, P;
Chester, K;
(2016)
Antibody-targeted nanoparticles for cancer treatment.
Immunotherapy
, 8
(8)
pp. 941-958.
10.2217/imt.16.11.
|
|
Carter, T;
Shawy, H;
Cohn-Brown, D;
Chester, K;
Mulholland, P;
(2016)
Ipilimumab and Bevacizumab in Glioblastoma.
Clinical Oncology
, 28
(10)
pp. 622-626.
10.1016/j.clon.2016.04.042.
|
|
|
Castillo, SD;
Tzouanacou, E;
Zaw-Thin, M;
Berenjeno, IM;
Parker, VE;
Chivite, I;
Milà-Guasch, M;
... Vanhaesebroeck, B; + view all
(2016)
Somatic activating mutations in Pik3ca cause sporadic venous malformations in mice and humans.
Science Translational Medicine
, 8
(332)
, Article 332ra43. 10.1126/scitranslmed.aad9982.
|
|
Castillo, SD;
Vanhaesebroeck, B;
Sebire, NJ;
(2016)
Phosphoinositide 3-kinase: a new kid on the block in vascular anomalies.
The Journal of Pathology
, 240
(4)
pp. 387-396.
10.1002/path.4802.
|
|
Caxaria, SMGL;
(2016)
Induced pluripotent stem cells (iPSCs) for research and therapy: induction of hepatic differentiation in iPSCs and evaluation of their quality as a model of in vivo development in the context of coagulation.
Doctoral thesis , UCL (University College London).
|
|
|
Chaganti, S;
Illidge, T;
Barrington, S;
Mckay, P;
Linton, K;
Cwynarski, K;
McMillan, A;
... British Committee for Standards in Haematology, British Committee for Standards in Haematology; + view all
(2016)
Guidelines for the management of diffuse large B-cell lymphoma.
Br J Haematol
, 174
(1)
pp. 43-56.
10.1111/bjh.14136.
|
|
|
Chakravarthy, A;
Henderson, S;
Thirdborough, SM;
Ottensmeier, CH;
Su, X;
Lechner, M;
Feber, A;
... Fenton, TR; + view all
(2016)
Human Papillomavirus Drives Tumor Development Throughout the Head and Neck: Improved Prognosis Is Associated With an Immune Response Largely Restricted to the Oropharynx.
Journal Of Clinical Oncology
, 34
(34)
pp. 4132-4141.
10.1200/JCO.2016.68.2955.
|
|
|
Chatterjee, M;
Turner, DC;
Felip, E;
Lena, H;
Cappuzzo, F;
Horn, L;
Garon, EB;
... Flotten, O; + view all
(2016)
Systematic evaluation of pembrolizumab dosing in patients with advanced non-small-cell lung cancer.
Annals of Oncology
, 27
(7)
pp. 1291-1298.
10.1093/annonc/mdw174.
|
|
Chen, L;
Ge, B;
Casale, FP;
Vasquez, L;
Kwan, T;
Garrido-Martín, D;
Watt, S;
... Soranzo, N; + view all
(2016)
Genetic Drivers of Epigenetic and Transcriptional Variation in Human Immune Cells.
Cell
, 167
(5)
1398-1414.e24.
10.1016/j.cell.2016.10.026.
|
|
Chen, Y;
Breeze, CE;
Zhen, S;
Beck, S;
Teschendorff, AE;
(2016)
Tissue-independent and tissue-specific patterns of DNA methylation alteration in cancer.
Epigenetics & Chromatin
, 9
, Article 10. 10.1186/s13072-016-0058-4.
|
|
|
Chervova, O;
Oksanen, L;
(2016)
Time reversal method with stabilizing boundary conditions for Photoacoustic tomography.
Inverse Problems
, 32
(12)
, Article 125004. 10.1088/0266-5611/32/12/125004.
|
|
Cheung, A;
Bax, HJ;
Josephs, DH;
Ilieva, KM;
Pellizzari, G;
Opzoomer, J;
Bloomfield, J;
... Karagiannis, SN; + view all
(2016)
Targeting folate receptor alpha for cancer treatment.
Oncotarget
, 7
(32)
pp. 52553-52574.
10.18632/oncotarget.9651.
|
|
|
Childs, A;
Kirkwood, A;
Edeline, J;
Tu, VL;
Watkins, J;
Lamarca, A;
Alrifai, D;
... Meyer, T; + view all
(2016)
Ki-67 index and response to chemotherapy in patients with neuroendocrine tumours.
Endocrine-Related Cancer
, 23
(7)
pp. 563-570.
10.1530/ERC-16-0099.
|
|
|
Childs, A;
Vesely, C;
Ensell, L;
Lowe, H;
Luong, TV;
Caplin, ME;
Toumpanakis, C;
... Meyer, T; + view all
(2016)
Expression of somatostatin receptors 2 and 5 in circulating tumour cells from patients with neuroendocrine tumours.
British Journal of Cancer
, 115
(12)
pp. 1540-1547.
10.1038/bjc.2016.377.
|
|
|
Chuang, LS;
Villaverde, N;
Hui, KY;
Mortha, A;
Rahman, A;
Levine, AP;
Haritunians, T;
... Cho, JH; + view all
(2016)
A Frameshift in CSF2RB Predominant Among Ashkenazi Jews Increases Risk for Crohn's Disease and Reduces Monocyte Signaling via GMCSF.
Gastroenterology
, 151
(4)
710-723.e2.
10.1053/j.gastro.2016.06.045.
|
|
Chung, R;
Maulik, A;
Hamarneh, A;
Hochhauser, D;
Hausenloy, DJ;
Walker, JM;
Yellon, DM;
(2016)
Effect of Remote Ischaemic Conditioning in ONCology patients undergoing chemotherapy: rationale and design of the ERIC-ONC study - a single-center, blinded, randomized controlled trial.
Clinical Cardiology
, 39
(2)
pp. 72-82.
10.1002/clc.22507.
|
|
|
Cohen, H;
Hunt, BJ;
Efthymiou, M;
Arachchillage, DR;
Mackie, IJ;
Clawson, S;
Sylvestre, Y;
... RAPS trial investigators, .; + view all
(2016)
Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial.
Lancet Haematology
, 3
(9)
e426-e436.
10.1016/S2352-3026(16)30079-5.
|
|
|
Cook, G;
Ashcroft, AJ;
Cairns, DA;
Williams, CD;
Brown, JM;
Cavenagh, JD;
Snowden, JA;
... National Cancer Research Institute Haemato-oncology Clinical Stu, .; + view all
(2016)
The effect of salvage autologous stem-cell transplantation on overall survival in patients with relapsed multiple myeloma (final results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial.
Lancet Haematology
, 3
(7)
e340-e351.
10.1016/S2352-3026(16)30049-7.
|
|
|
Cortés, E;
Huidobro, PA;
Sinclair, HG;
Guldbrand, S;
Peveler, WJ;
Davies, T;
Parrinello, S;
... Maier, SA; + view all
(2016)
Plasmonic Nanoprobes for Stimulated Emission Depletion Nanoscopy.
ACS Nano
, 10
(11)
pp. 10454-10461.
10.1021/acsnano.6b06361.
|
|
Coulter, TI;
Chandra, A;
Bacon, CM;
Babar, J;
Curtis, J;
Screaton, N;
Goodlad, JR;
... Cant, AJ; + view all
(2016)
Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: A large patient cohort study.
J Allergy Clin Immunol
10.1016/j.jaci.2016.06.021.
|
|
|
Crockford, AJ;
(2016)
Deciphering tetraploid tolerance.
Doctoral thesis , UCL (University College London).
|
|
|
Crowley, C;
Klanrit, P;
Butler, CR;
Varanou, A;
Platé, M;
Hynds, RE;
Chambers, RC;
... Janes, SM; + view all
(2016)
Surface modification of a POSS-nanocomposite material to enhance cellular integration of a synthetic bioscaffold.
Biomaterials
, 83
pp. 283-293.
10.1016/j.biomaterials.2016.01.005.
|
|
D
|
Dangoor, A;
Seddon, B;
Gerrand, C;
Grimer, R;
Whelan, J;
Judson, I;
(2016)
UK guidelines for the management of soft tissue sarcomas.
Clinical Sarcoma Research
, 6
, Article 20. 10.1186/s13569-016-0060-4.
|
|
|
de Boer, SM;
Powell, ME;
Mileshkin, L;
Katsaros, D;
Bessette, P;
Haie-Meder, C;
Ottevanger, PB;
... Creutzberg, CL; + view all
(2016)
Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): an open-label, multicentre, randomised, phase 3 trial.
Lancet Oncology
, 17
(8)
pp. 1114-1126.
10.1016/S1470-2045(16)30120-6.
|
|
|
De Ruysscher, D;
Lueza, B;
Le Péchoux, C;
Johnson, DH;
O'Brien, M;
Murray, N;
Spiro, S;
... RTT-SCLC Collaborative Group; + view all
(2016)
Impact of thoracic radiotherapy timing in limited-stage small-cell lung cancer: usefulness of the individual patient data meta-analysis.
Annals of Oncology
, 27
(10)
pp. 1818-1828.
10.1093/annonc/mdw263.
|
|
|
Dey, A;
(2016)
Enhancing the neutrophil-mediated anti-cancer response after oncolytic measles virus therapy in B cell malignancy: dissecting out the mechanism.
Doctoral thesis , UCL (University College London).
|
 |
|
Dillon, M;
Ellis, S;
Grove, L;
McLellan, L;
Clack, G;
Smith, S;
Laude, J;
... Harrington, K; + view all
(2016)
PATRIOT: A phase I study to assess the tolerability, safety and biological effects of a specific ataxia telangiectasia and Rad3-related (ATR) inhibitor (AZD6738) as a single agent and in combination with palliative radiation therapy in patients with solid tumours.
Presented at: ASCO 2016 Annual Meeting: Poster Session, Developmental Therapeutics - Clinical Pharmacology and Experimental Therapeutics, Chicago.
|
|
Dirix, L;
Swaisland, H;
Verheul, HMW;
Rottey, S;
Leunen, K;
Jerusalem, G;
Rolfo, C;
... Plummer, R; + view all
(2016)
Effect of Itraconazole and Rifampin on the Pharmacokinetics of Olaparib in Patients With Advanced Solid Tumors: Results of Two Phase I Open-label Studies.
Clinical Therapeutics
, 38
(10)
pp. 2286-2299.
10.1016/j.clinthera.2016.08.010.
|
|
Domingo, E;
Freeman-Mills, L;
Rayner, E;
Glaire, M;
Briggs, S;
Vermeulen, L;
Fessler, E;
... Church, DN; + view all
(2016)
Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study.
Lancet Gastroenterology and Hepatology
, 1
(3)
pp. 207-216.
10.1016/S2468-1253(16)30014-0.
|
|
|
Dondelinger, Y;
Darding, M;
Bertrand, MJ;
Walczak, H;
(2016)
Poly-ubiquitination in TNFR1-mediated necroptosis.
Cellular Molecular Life Sciences
, 73
(11)
pp. 2165-2176.
10.1007/s00018-016-2191-4.
|
|
|
Downes, RJ;
Vassiliev, D;
(2016)
Spectral theoretic characterization of the massless Dirac action.
Mathematika
, 62
pp. 701-718.
10.1112/S0025579315000509.
|
|
|
Drummond, CJ;
Esfandiari, A;
Liu, J;
Lu, X;
Hutton, C;
Jackson, J;
Bennaceur, K;
... Lunec, J; + view all
(2016)
TP53 mutant MDM2-amplified cell lines selected for resistance to MDM2-p53 binding antagonists retain sensitivity to ionizing radiation.
Oncotarget
, 7
(29)
pp. 46203-46218.
10.18632/oncotarget.10073.
|
|
|
Dvorkina, M;
Nieddu, V;
Chakelam, S;
Pezzolo, A;
Cantilena, S;
Leite, AP;
Chayka, O;
... Salomoni, P; + view all
(2016)
A promyelocytic leukemia protein-thrombospondin 2 axis and the risk of relapse in neuroblastoma.
Clinical Cancer Research
, 22
(13)
pp. 3398-3409.
10.1158/1078-0432.CCR-15-2081.
|
E
|
Ebinger, S;
Oezdemir, EZ;
Ziegenhain, C;
Tiedt, S;
Alves, CC;
Grunert, M;
Dworzak, M;
... Jeremias, I; + view all
(2016)
Characterization of Rare, Dormant, and Therapy-Resistant Cells in Acute Lymphoblastic Leukemia.
Cancer Cell
, 30
(6)
pp. 849-862.
10.1016/j.ccell.2016.11.002.
|
|
|
Edeline, J;
Blanc, JF;
Johnson, P;
Campillo-Gimenez, B;
Ross, P;
Ma, YT;
King, J;
... Meyer, T; + view all
(2016)
A multicentre comparison between Child Pugh and Albumin-Bilirubin scores in patients treated with sorafenib for Hepatocellular Carcinoma.
Liver International
, 36
(12)
pp. 1821-1828.
10.1111/liv.13170.
|
|
El-Sharkawi, D;
(2016)
Studies to Investigate Epigenetic Factors in Acute Myeloid Leukaemia.
Doctoral thesis , UCL (University College London).
|
|
Eminowicz, GKD;
(2016)
Standardisation and optimisation of radical radiotherapy for cervical cancer.
Doctoral thesis , UCL (University College London).
|
|
Engert, A;
Balduini, C;
Brand, A;
Coiffier, B;
Cordonnier, C;
Doehner, H;
de Wit, TD;
... Zieger, B; + view all
(2016)
The European Hematology Association Roadmap for European Hematology Research: a consensus document.
Haematologica
, 101
(2)
pp. 115-208.
10.3324/haematol.2015.136739.
|
|
Esfandiari, A;
Hawthorne, TA;
Nakjang, S;
Lunec, J;
(2016)
Chemical Inhibition of Wild-Type p53-Induced Phosphatase 1 (WIP1/PPM1D) by GSK2830371 Potentiates the Sensitivity to MDM2 Inhibitors in a p53-Dependent Manner.
Molecular Cancer Therapeutics
, 15
(3)
pp. 379-391.
10.1158/1535-7163.MCT-15-0651.
|
|
|
Evans, IC;
Barnes, JL;
Garner, IM;
Pearce, DR;
Maher, TM;
Shi-Wen, X;
Renzoni, EA;
... McAnulty, RJ; + view all
(2016)
Epigenetic Regulation of Cyclooxygenase-2 by methylation of c8orf4 in Pulmonary Fibrosis.
Clinical Science
, 130
(8)
pp. 575-586.
10.1042/CS20150697.
|
F
|
Feber, A;
Worth, DC;
Chakravarthy, A;
de Winter, P;
Shah, K;
Arya, M;
Saqib, M;
... Kelly, JD; + view all
(2016)
CSN1 Somatic Mutations in Penile Squamous Cell Carcinoma.
Cancer Research
, 76
(16)
pp. 4720-4727.
10.1158/0008-5472.CAN-15-3134.
|
|
Fessler, E;
Drost, J;
van Hooff, SR;
Linnekamp, JF;
Wang, X;
Jansen, M;
De Sousa E Melo, F;
... Medema, JP; + view all
(2016)
TGFβ signaling directs serrated adenomas to the mesenchymal colorectal cancer subtype.
EMBO Molecular Medicine
, 8
(7)
pp. 745-760.
10.15252/emmm.201606184.
|
|
|
Findlay, JM;
Castro-Giner, F;
Makino, S;
Rayner, E;
Kartsonaki, C;
Cross, W;
Kovac, M;
... Tomlinson, I; + view all
(2016)
Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy.
Nature Communications
, 7
, Article 11111. 10.1038/ncomms11111.
|
|
|
Flores-Borja, F;
Irshad, S;
Gordon, P;
Wong, F;
Sheriff, I;
Tutt, A;
Ng, T;
(2016)
Crosstalk between Innate Lymphoid Cells and Other Immune Cells in the Tumor Microenvironment.
Journal of Immunology Research
, Article 7803091. 10.1155/2016/7803091.
|
|
|
Flynn, MJ;
(2016)
Mechanistic and pharmacodynamic studies of ADCT-301, an Antibody Drug Conjugate targeting CD25-expressing haematological malignancies.
Doctoral thesis , UCL (University College London).
|
|
Flynn, MJ;
Zammarchi, F;
Tyrer, PC;
Akarca, AU;
Janghra, N;
Britten, CE;
Havenith, CEG;
... Hartley, JA; + view all
(2016)
ADCT-301, a Pyrrolobenzodiazepine (PBD) Dimer-Containing Antibody-Drug Conjugate (ADC) Targeting CD25-Expressing Hematological Malignancies.
Molecular Cancer Therapeutics
, 15
(11)
pp. 2709-2721.
10.1158/1535-7163.MCT-16-0233.
|
|
Forster, M;
Mendes, R;
Harrington, K;
Guerrero-Urbano, T;
Baines, H;
Spanswick, V;
Ensell, L;
... Beare, S; + view all
(2016)
A phase I study of olaparib in addition to cisplatin-based concurrent chemoradiotherapy for patients with high risk locally advanced squamous cell carcinoma of the head and neck (HNSCC).
Presented at: 2016 ASCO Annual Meeting, Chicago, IL, USA.
|
|
Foxall, E;
Pipili, A;
Jones, GE;
Wells, CM;
(2016)
Significance of kinase activity in the dynamic invadosome.
European Journal of Cell Biology
, 95
(11)
pp. 483-492.
10.1016/j.ejcb.2016.07.002.
|
|
|
Franklin, JM;
Sharma, RA;
Harris, AL;
Gleeson, FV;
(2016)
Imaging oligometastatic cancer before local treatment.
The Lancet Oncology
, 17
(9)
e406-e414.
10.1016/S1470-2045(16)30277-7.
|
|
|
Fujimitsu, K;
Grimaldi, M;
Yamano, H;
(2016)
Cyclin dependent kinase 1-dependent activation of APC/C ubiquitin ligase.
Science
, 352
(6289)
pp. 1121-1124.
10.1126/science.aad3925.
|
|
|
Furness, AJ;
Quezada, SA;
Peggs, KS;
(2016)
Neoantigen heterogeneity: a key driver of immune response and sensitivity to immune checkpoint blockade?
[Editorial comment].
Immunotherapy
, 8
(7)
pp. 763-766.
10.2217/imt-2016-0064.
|
G
|
Gaifulina, R;
Maher, AT;
Kendall, C;
Nelson, J;
Rodriguez-Justo, M;
Lau, K;
Thomas, GM;
(2016)
Label-free Raman spectroscopic imaging to extract morphological and chemical information from a formalin-fixed, paraffin-embedded rat colon tissue section.
International Journal of Experimental Pathology
, 97
(4)
pp. 337-350.
10.1111/iep.12194.
|
|
Garbowski, MW;
Ma, Y;
Fucharoen, S;
Srichairatanakool, S;
Hider, R;
Porter, JB;
(2016)
Clinical and methodological factors affecting non-transferrin-bound iron values using a novel fluorescent bead assay.
Translational Research
, 177
19-30.e5.
10.1016/j.trsl.2016.05.005.
|
|
|
Gardiner, C;
Kiyoko, K;
Patel, I;
Lane, P;
Machin, SJ;
Mackie, I;
(2016)
A performance evaluation of a novel human recombinant tissue factor prothrombin time reagent.
Presented at: UNSPECIFIED.
|
|
|
Gardiner, C;
Lane, P;
Chitolie, A;
Nunn, M;
Kurono, H;
Machin, S;
Mackie, I;
(2016)
AUTOMATED ASSESSMENT OF THE COMPLEMENT SYSTEM.
Presented at: UNSPECIFIED.
|
|
Gardiner, C;
Patel, I;
Lane, P;
Kiyoko, K;
Machin, S;
Mackie, I;
(2016)
A NOVEL PROTHROMBIN TIME REAGENT THAT UTILISES TISSUE FACTOR GENERATED BY SILK-WORM-BACULOVIRUS TECHNOLOGY.
Presented at: UNSPECIFIED.
|
|
|
Genadieva-Stavrik, S;
Boumendil, A;
Dreger, P;
Peggs, K;
Briones, J;
Corradini, P;
Bacigalupo, A;
... Sureda, A; + view all
(2016)
Myeloablative versus reduced intensity allogeneic stem cell transplantation for relapsed/refractory Hodgkin's lymphoma in recent years: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
Annals of Oncology
, 27
(12)
pp. 2251-2257.
10.1093/annonc/mdw421.
|
|
Germain, DP;
Hughes, DA;
Nicholls, K;
Bichet, DG;
Giugliani, R;
Wilcox, WR;
Feliciani, C;
... Schiffmann, R; + view all
(2016)
Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat.
New England Journal of Medicine
, 375
(6)
pp. 545-555.
10.1056/NEJMoa1510198.
|
|
|
Gillessen, S;
Omlin, A;
Attard, G;
de Bono, JS;
Efstathiou, E;
Fizazi, K;
Halabi, S;
... Tombal, B; + view all
(2016)
Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015.
Annals of Oncology
, 26
pp. 1589-1604.
10.1093/annonc/mdw180.
|
|
|
Giugliani, R;
Niu, DM;
Ramaswami, U;
West, M;
Hughes, D;
Kampmann, C;
Pintos-Morell, G;
... Beck, M; + view all
(2016)
A 15-year perspective of the fabry outcome survey.
Journal of Inborn Errors of Metabolism and Screening
, 4
10.1177/2326409816666298.
|
|
|
Gleeson, M;
Hawkes, EA;
Cunningham, D;
Chadwick, N;
Counsell, N;
Lawrie, A;
Jack, A;
... Linch, D; + view all
(2016)
Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) in the management of primary mediastinal B-cell lymphoma: a subgroup analysis of the UK NCRI R-CHOP 14 versus 21 trial.
British Journal of Haematology
, 175
(4)
pp. 668-672.
10.1111/bjh.14287.
|
|
Goekbuget, N;
Dombret, H;
Ribera, J-M;
Fielding, AK;
Advani, A;
Bassan, R;
Chia, V;
... Kantarjian, H; + view all
(2016)
International reference analysis of outcomes in adults with B-precursor Ph-negative relapsed/refractory acute lymphoblastic leukemia.
Haematologica
, 101
(12)
pp. 1524-1533.
10.3324/haematol.2016.144311.
|
|
Goel, A;
Christudoss, P;
George, R;
Ramakrishna, B;
Amirtharaj, GJ;
Keshava, SN;
Ramachandran, A;
... Eapen, CE; + view all
(2016)
Arsenicosis, possibly from contaminated groundwater, associated with noncirrhotic intrahepatic portal hypertension.
Indian J Gastroenterol
, 35
(3)
pp. 207-215.
10.1007/s12664-016-0660-1.
|
|
Goh, G;
Schmid, R;
Guiver, K;
Arpornwirat, W;
Chitapanarux, I;
Ganju, V;
Im, SA;
... Swanton, C; + view all
(2016)
Clonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- Vinorelbine.
PLOS Med
, 13
(12)
, Article e1002136. 10.1371/journal.pmed.1002136.
|
|
Gökbuget, N;
Kelsh, M;
Chia, V;
Advani, A;
Bassan, R;
Dombret, H;
Doubek, M;
... Kantarjian, H; + view all
(2016)
Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia.
Blood Cancer J
, 6
(9)
, Article e473. 10.1038/bcj.2016.84.
|
|
|
Goncalves, MR;
(2016)
Characterisation of cycling tumour hypoxia with magnetic resonance imaging.
Doctoral thesis , UCL (University College London).
|
|
|
Griffiths, PD;
Rothwell, E;
Raza, M;
Wilmore, S;
Doyle, T;
Harber, M;
O'Beirne, J;
... Emery, VC; + view all
(2016)
Randomized Controlled Trials to Define Viral Load Thresholds for Cytomegalovirus Pre-Emptive Therapy.
PLoS One
, 11
(9)
, Article e0163722. 10.1371/journal.pone.0163722.
|
|
Grunewald, T;
Ledermann, JA;
(2016)
Targeted Therapies for Ovarian Cancer.
Best Practice & Research Clinical Obstetrics & Gynaecology
10.1016/j.bpobgyn.2016.12.001.
(In press).
|
|
Gu, Z;
Churchman, M;
Roberts, K;
Li, Y;
Liu, Y;
Harvey, RC;
McCastlain, K;
... Mullighan, CG; + view all
(2016)
Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia.
Nature Communications
, 7
, Article 13331. 10.1038/ncomms13331.
|
|
|
Gunnell, A;
Webb, HM;
Wood, CD;
McClellan, MJ;
Wichaidit, B;
Kempkes, B;
Jenner, RG;
... West, MJ; + view all
(2016)
RUNX super-enhancer control through the Notch pathway by Epstein-Barr virus transcription factors regulates B cell growth.
Nucleic Acids Research
, 44
(10)
, Article 4636-4650. 10.1093/nar/gkw085.
|
|
H
|
Hachani, R;
Lowdell, M;
Birchall, M;
Hervault, A;
Mertz, D;
Begin-Colin, S;
Thanh, NT;
(2016)
Polyol synthesis, functionalisation, and biocompatibility studies of superparamagnetic iron oxide nanoparticles as potential MRI contrast agents.
Nanoscale
, 8
(6)
pp. 3278-3287.
10.1039/c5nr03867g.
|
|
|
Hájek, R;
Masszi, T;
Petrucci, MT;
Palumbo, A;
Rosiñol, L;
Nagler, A;
Yong, KL;
... Ludwig, H; + view all
(2016)
A randomized phase III study of carfilzomib vs low-dose corticosteroids with optional cyclophosphamide in relapsed and refractory multiple myeloma (FOCUS).
Leukemia
, 31
(1)
pp. 107-114.
10.1038/leu.2016.176.
|
|
|
Hall, AR;
Burke, N;
Dongworth, RK;
Kalkhoran, SB;
Dyson, A;
Vicencio, JM;
Dorn Ii, GW;
... Hausenloy, DJ; + view all
(2016)
Hearts deficient in both Mfn1 and Mfn2 are protected against acute myocardial infarction.
Cell Death and Disease
, 7
, Article e2238. 10.1038/cddis.2016.139.
|
|
|
Halligan, S;
Boone, D;
Bhatnagar, G;
Ahmad, T;
Bloom, S;
Rodriguez-Justo, M;
Taylor, SA;
(2016)
Prognostic biomarkers to identify patients destined to develop severe Crohn's disease who may benefit from early biological therapy: protocol for a systematic review, meta-analysis and external validation.
Syst Rev
, 5
, Article 206. 10.1186/s13643-016-0383-5.
|
|
|
Harrington, K;
Forster, M;
Dillon, M;
Grove, L;
Adeleke, S;
Chen, S;
Diamond, J;
... Greenberg, J; + view all
(2016)
Patritumab or Placebo Plus Cetuximab and Platinum-Based Therapy in Squamous Cell Carcinoma of the Head and Neck (SCCHN): a Phase 2 Study.
Presented at: ASCO 2016 Annual Meeting: Poster Session, Head and Neck Cancer, Chicago.
|
|
Heinrich, M;
Fisher, A;
Paton, B;
McCourt, O;
Beeken, RJ;
Hackshaw, A;
Wardle, J;
(2016)
Lifestyle in Multiple Myeloma - a longitudinal cohort study protocol.
BMC Cancer
, 16
, Article 387. 10.1186/s12885-016-2407-x.
|
|
|
Hendriksz, CJ;
Berger, KI;
Parini, R;
AlSayed, MD;
Raiman, J;
Giugliani, R;
Mitchell, JJ;
... Harmatz, PR; + view all
(2016)
Impact of long-term elosulfase alfa treatment on respiratory function in patients with Morquio A syndrome.
Journal of Inherited Metabolic Disease
, 39
(6)
pp. 839-847.
10.1007/s10545-016-9973-6.
|
|
|
Hendriksz, CJ;
Parini, R;
AlSayed, MD;
Raiman, J;
Giugliani, R;
Solano Villarreal, ML;
Mitchell, JJ;
... Harmatz, PR; + view all
(2016)
Long-term endurance and safety of elosulfase alfa enzyme replacement therapy in patients with Morquio A syndrome.
Molecular Genetics and Metabolism
, 119
(1-2)
pp. 131-143.
10.1016/j.ymgme.2016.05.018.
|
|
|
Henson, KE;
Reulen, RC;
Winter, DL;
Bright, CJ;
Fidler, MM;
Frobisher, C;
Guha, J;
... Hawkins, MM; + view all
(2016)
Cardiac Mortality Among 200 000 Five-Year Survivors of Cancer Diagnosed at 15 to 39 Years of Age: The Teenage and Young Adult Cancer Survivor Study.
Circulation
, 134
(20)
pp. 1519-1531.
10.1161/CIRCULATIONAHA.116.022514.
|
|
Herrero, J;
Muffato, M;
Beal, K;
Fitzgerald, S;
Gordon, L;
Pignatelli, M;
Vilella, AJ;
... Flicek, P; + view all
(2016)
Database: The Journal of Biological Databases and Curation.
Database (Oxford)
, 2016
pp. 1-17.
10.1093/database/bav096.
|
|
|
Hertweck, A;
Evans, CM;
Eskandarpour, M;
Lau, JC;
Oleinika, K;
Jackson, I;
Kelly, A;
... Jenner, RG; + view all
(2016)
T-bet Activates Th1 Genes through Mediator and the Super Elongation Complex.
Cell Reports
, 15
(12)
pp. 2756-2770.
10.1016/j.celrep.2016.05.054.
|
|
Hiley, CT;
Le Quesne, J;
Santis, G;
Sharpe, R;
De Castro, DG;
Middleton, G;
Swanton, C;
(2016)
Challenges in molecular testing in non-small-cell lung cancer patients with advanced disease.
The Lancet
, 388
(10048)
pp. 1002-1011.
10.1016/S0140-6736(16)31340-X.
|
|
|
Hirst, Y;
Kerrison, R;
Kobayashi, LC;
Counsell, N;
Djedovic, N;
Ruwende, J;
Stewart, M;
(2016)
Text Reminders in Colorectal Cancer Screening (TRICCS): Protocol for a randomised controlled trial.
BMC Public Health
10.1186/s12889-016-2733-6.
|
|
|
Holler, A;
Zech, M;
Ghorashian, S;
Pike, R;
Hotblack, A;
Velica, P;
Xue, S-A;
... Stauss, HJ; + view all
(2016)
Expression of a dominant T-cell receptor can reduce toxicity and enhance tumor protection of allogeneic T-cell therapy.
Haematologica
, 101
(4)
pp. 482-490.
10.3324/haematol.2015.132712.
|
|
|
Hopper, C;
Jerjes, W;
Sultan, A;
Forster, M;
carnell, D;
Simeon, C;
Berg, K;
... Hamdoon, Z; + view all
(2016)
Disulfonated tetraphenyl chlorin (TPCS2a)–induced photochemical internalisation of bleomycin in patients with solid malignancies: A first-in-man phase I dose escalation clinical trial.
The Lancet Oncology
, 17
(9)
pp. 1217-1229.
10.1016/S1470-2045(16)30224-8.
|
|
Hotblack, A;
Seshadri, S;
Zhang, L;
Hamrang-Yousefi, S;
Chakraverty, R;
Escors, D;
Bennett, CL;
(2016)
Dendritic Cells Cross-Present Immunogenic Lentivector-Encoded Antigen from Transduced Cells to Prime Functional T Cell Immunity.
Molecular Therapy
, 25
(2)
pp. 504-511.
10.1016/j.ymthe.2016.11.001.
|
|
Hughes, A;
Landers, D;
Arkenau, H-T;
Shah, S;
Stephens, R;
Mahal, A;
Simmons, M;
... Royle, J; + view all
(2016)
Development and Evaluation of a New Technological Way of Engaging Patients and Enhancing Understanding of Drug Tolerability in Early Clinical Development: PROACT.
Advances in Therapy
, 33
(6)
pp. 1012-1024.
10.1007/s12325-016-0335-4.
|
|
Hughes, DA;
(2016)
Fabry disease: will markers of early disease enable early treatment and better outcomes?
Current Opinion in Cardiology
, 31
(4)
pp. 434-439.
10.1097/HCO.0000000000000308.
|
|
Hynds, RE;
(2016)
Characterisation of cultured airway basal cells to understand their role in human lung disease.
Doctoral thesis , UCL (University College London).
|
|
Hynds, RE;
Butler, CR;
Janes, SM;
Giangreco, A;
(2016)
Expansion of Human Airway Basal Stem Cells and Their Differentiation as 3D Tracheospheres.
Organoids: Methods in Molecular Biology
, 1576
pp. 43-53.
10.1007/7651_2016_5.
|
I
|
Ip, LRH;
(2016)
Effect of INPP4B loss on DNA repair and treatment strategies in ovarian cancer.
Doctoral thesis , UCL (University College London).
|
|
|
Isabelle, M;
Dorney, J;
Lewis, A;
Lloyd, GR;
Old, O;
Shepherd, N;
Rodriguez-Justo, M;
... Kendall, C; + view all
(2016)
Multi-centre Raman spectral mapping of oesophageal cancer tissues: a study to assess system transferability.
Faraday Discussions
, 187
pp. 87-103.
10.1039/c5fd00183h.
|
|
|
Ivey, A;
Hills, RK;
Simpson, MA;
Jovanovic, JV;
Gilkes, A;
Grech, A;
Patel, Y;
... Grimwade, D; + view all
(2016)
Assessment of Minimal Residual Disease in Standard-Risk AML.
The New England Journal Medicine
, 374
(5)
pp. 422-433.
10.1056/NEJMoa1507471.
|
J
|
Jacobs, JG;
Johnston, E;
Freeman, A;
Patel, D;
Rodriguez-Justo, M;
Atkinson, D;
Punwani, S;
... Panagiotaki, E; + view all
(2016)
Histological validation of VERDICT cellularity map in a prostatectomy case.
Presented at: International Society for Magnetic Resonance in Medicine 24th Annual Meeting, Singapore.
|
|
James, ND;
Sydes, MR;
Clarke, NW;
Mason, MD;
Dearnaley, DP;
Spears, MR;
Ritchie, AW;
... STAMPEDE investigators; + view all
(2016)
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial.
Lancet
, 387
(10024)
pp. 1163-1177.
10.1016/S0140-6736(15)01037-5.
|
|
Jansen, M;
Wright, NA;
(2016)
Distal Esophageal Adenocarcinoma and Gastric Adenocarcinoma: Time for a Shared Research Agenda.
Stem Cells, Pre-neoplasia, and Early Cancer of the Upper Gastrointestinal Tract
, 908
pp. 1-8.
10.1007/978-3-319-41388-4_1.
|
|
Johnson, P;
Federico, M;
Kirkwood, A;
Fossa, A;
Berkahn, L;
Carella, A;
d'Amore, F;
... Barrington, S; + view all
(2016)
Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma.
New England Journal of Medicine
, 374
(25)
pp. 2419-2429.
10.1056/NEJMoa1510093.
|
|
|
Johnson, SP;
Ramasawmy, R;
Campbell-Washburn, AE;
Wells, JA;
Robson, M;
Rajkumar, V;
Lythgoe, MF;
... Walker-Samuel, S; + view all
(2016)
Acute changes in liver tumour perfusion measured non-invasively with arterial spin labelling.
British Journal of Cancer
, 114
(8)
pp. 897-904.
10.1038/bjc.2016.51.
|
|
|
Johnston, EW;
Pye, H;
Bonet Carne, E;
Panagiotaki, E;
Patel, D;
Galazi, M;
Heavey, S;
... Punwani, S; + view all
(2016)
INNOVATE: A prospective cohort study combining serum and urinary biomarkers with novel diffusion-weighted magnetic resonance imaging for the prediction and characterization of prostate cancer.
BMC Cancer
, 16
(816)
10.1186/s12885-016-2856-2.
|
|
Jorgensen, M;
(2016)
Targeted Therapy for Chordoma.
Doctoral thesis , UCL (University College London).
|
|
|
Jovanovic, KK;
Tanic, M;
Ivanovic, I;
Gligorijevic, N;
Dojcinovic, BP;
Radulovic, S;
(2016)
Cell cycle, apoptosis, cellular uptake and whole-transcriptome microarray gene expression analysis of HeLa cells treated with a ruthenium(II)-arene complex with an isoquinoline-3-carboxylic acid ligand.
Journal of Inorganic Biochemistry
, 163
pp. 362-373.
10.1016/j.jinorgbio.2016.04.011.
|
|
K
|
Kanu, N;
Cerone, MA;
Goh, G;
Zalmas, L-P;
Bartkova, J;
Dietzen, M;
McGranahan, N;
... Swanton, C; + view all
(2016)
DNA replication stress mediates APOBEC3 family mutagenesis in breast cancer.
Genome Biology
, 17
, Article 185. 10.1186/s13059-016-1042-9.
|
|
|
Kerrison, R;
McGregor, LM;
Marshall, S;
Isitt, J;
Counsell, N;
Wardle, J;
Von Wagner, C;
(2016)
Use of a twelve month's self referral reminder to faciliate uptake of bowel scope (flexible sigmoidoscopy screening) in previous non-responders: a London-based feasibility study.
British Journal of Cancer
, 114
pp. 751-758.
10.1038/bjc.2016.43.
|
|
|
Kerrison, RS;
McGregor, LM;
Marshall, S;
Isitt, J;
Counsell, N;
Wardle, J;
von Wagner, C;
(2016)
Use of a 12 months' self-referral reminder to facilitate uptake of bowel scope (flexible sigmoidoscopy) screening in previous non-responders: a London-based feasibility study.
British Journal of Cancer
, 114
(7)
pp. 751-758.
10.1038/bjc.2016.43.
|
|
|
Khoja, L;
Nolan, K;
Mekki, R;
Milani, A;
Mescallado, N;
Ashcroft, L;
Hasan, J;
... Jayson, GC; + view all
(2016)
Improved Survival from Ovarian Cancer in Patients Treated in Phase III Trial Active Cancer Centres in the UK.
Clinical Oncology
, 28
(12)
pp. 760-765.
10.1016/j.clon.2016.06.011.
|
|
|
Kinna, A;
Tolner, B;
Rota, EM;
Titchener-Hooker, N;
Nesbeth, D;
Chester, K;
(2016)
IMAC capture of recombinant protein from unclarified mammalian cell feed streams.
Biotechnology and Bioengineering
, 113
(1)
pp. 130-140.
10.1002/bit.25705.
|
|
|
Koeferle, A;
Worf, K;
Breunig, C;
Baumann, V;
Herrero, J;
Wiesbeck, M;
Hutter, LH;
... Stricker, SH; + view all
(2016)
CORALINA: a universal method for the generation of gRNA libraries for CRISPR-based screening.
BMC Genomics
, 17
, Article 917. 10.1186/s12864-016-3268-z.
|
|
|
Konecny, G;
Kristeleit, RS;
(2016)
PARP inhibitors for BRCA1/2-mutated and sporadic ovarian cancer: current practice and future directions.
British Journal of Cancer
, 115
pp. 1157-1173.
10.1038/bjc.2016.311.
|
|
|
Kotwinski, PJ;
Smith, G;
Cooper, J;
Sanders, J;
Ma, L;
Teis, A;
Kotwinski, D;
... Breast cancer Early disease: Toxicity from Therapy with Epirubic; + view all
(2016)
Body Surface Area and Baseline Blood Pressure Predict Subclinical Anthracycline Cardiotoxicity in Women Treated for Early Breast Cancer.
PLOS One
, 11
(12)
, Article e0165262. 10.1371/journal.pone.0165262.
|
|
|
Kristeleit, RS;
Miller, RE;
Kohn, EC;
(2016)
Gynecologic Cancers: Emerging Novel Strategies for Targeting DNA Repair Deficiency.
American Society of Clinical Oncology Educational Book
, 2016
10.14694/EDBK_159086.
|
|
|
Krusche, B;
Ottone, C;
clements, MP;
Johnstone, ER;
Goetsch, K;
Lieven, H;
Mota, SG;
... Parrinello, S; + view all
(2016)
EphrinB2 drives perivascular invasion and proliferation of glioblastoma stem-like cells.
eLife
, 5
, Article e14845. 10.7554/eLife.14845.
|
|
|
Kularatne, B;
Arora, R;
Elshstein, G;
Guppy, N;
Kirkwood, A;
Meyer, T;
Kristeleit, RS;
(2016)
Immunohistochemistry (IHC) evaluation of a novel 4-protein prognostic and predictive biomarker panel in endometrial cancer (EC).
In:
Abstract Book of the 41st ESMO Congress (ESMO 2016), 7-11 October 2016, Copenhagen, Denmar.
Oxford University Press (OUP): Policy A1
|
|
Kumar, AJ;
Gimotty, PA;
Gelfand, J;
Buck, G;
Rowe, JM;
Goldstone, AH;
Fielding, A;
... Loren, AW; + view all
(2016)
Delays in postremission chemotherapy for Philadelphia chromosome negative acute lymphoblastic leukemia are associated with inferior outcomes in patients who undergo allogeneic transplant: An analysis from ECOG 2993/MRC UK ALLXII.
American Journal of Hematology
, 91
(11)
pp. 1107-1112.
10.1002/ajh.24497.
|
|
|
Kupka, S;
De Miguel, D;
Draber, P;
Martino, L;
Surinova, S;
Rittinger, K;
Walczak, H;
(2016)
SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes.
Cell Reports
, 16
(9)
pp. 2271-2280.
10.1016/j.celrep.2016.07.086.
|
L
|
Laethem, J-LV;
Riess, H;
Jassem, J;
Haas, M;
Martens, UM;
Weekes, C;
Peeters, M;
... Childs, BH; + view all
(2016)
Phase I/II Study of Refametinib (BAY 86-9766) in Combination with Gemcitabine in Advanced Pancreatic cancer.
Targeted Oncology
, 12
(1)
pp. 97-109.
10.1007/s11523-016-0469-y.
|
|
|
Lampada, A;
(2016)
Targeting autophagy in colorectal cancer.
Doctoral thesis , UCL (University College London).
|
|
Landau, DB;
Hughes, L;
Baker, A;
Bates, AT;
Bayne, MC;
Counsell, N;
Garcia-Alonso, A;
... Fenwick, JD; + view all
(2016)
IDEAL-CRT: A Phase 1/2 Trial of Isotoxic Dose-Escalated Radiation Therapy and Concurrent Chemotherapy in Patients With Stage II/III Non-Small Cell Lung Cancer.
International Journal of Radiation Oncology - Biology - Physics
, 95
(5)
pp. 1367-1377.
10.1016/j.ijrobp.2016.03.031.
|
|
|
Laskaratos, F-M;
Walker, M;
Naik, K;
Maragkoudakis, E;
Oikonomopoulos, N;
Grant, L;
Meyer, T;
... Toumpanakis, C; + view all
(2016)
Predictive factors of antiproliferative activity of octreotide LAR as first-line therapy for advanced neuroendocrine tumours.
British Journal of Cancer
, 115
(11)
pp. 1321-1327.
10.1038/bjc.2016.349.
|
|
Lawson, C;
Vicencio, JM;
Yellon, DM;
Davidson, SM;
(2016)
Microvesicles and exosomes: new players in metabolic and cardiovascular disease.
Journal of Endocrinology
, 228
(2)
R57-R71.
10.1530/JOE-15-0201.
|
|
Lazaryan, A;
Wang, T;
Spellman, SR;
Wang, HL;
Pidala, J;
Nishihori, T;
Askar, M;
... Lee, SJ; + view all
(2016)
Human leukocyte antigen supertype matching after myeloablative hematopoietic cell transplantation with 7/8 matched unrelated donor allografts: a report from the Center for International Blood and Marrow Transplant Research.
Haematologica
, 101
(10)
pp. 1267-1274.
10.3324/haematol.2016.143271.
|
|
Ledermann, JA;
(2016)
PARP inhibitors in ovarian cancer.
Annals of Oncology
, 27
(Suppl 1)
i40-i44.
10.1093/annonc/mdw094.
|
|
Ledermann, JA;
Drew, Y;
Kristeleit, RS;
(2016)
Homologous recombination deficiency and ovarian cancer.
European Journal of Cancer
, 60
pp. 49-58.
10.1016/j.ejca.2016.03.005.
|
|
Ledermann, JA;
Embleton, AC;
Raja, F;
Perren, TJ;
Jayson, GC;
Rustin, GJS;
Kaye, SB;
... Collaborators, I; + view all
(2016)
Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trial.
Lancet
, 387
(10023)
pp. 1066-1074.
10.1016/S0140-6736(15)01167-8.
|
|
Ledermann, JA;
Harter, P;
Gourley, C;
Friedlander, M;
Vergote, I;
Rustin, G;
Scott, C;
... Matulonis, U; + view all
(2016)
Quality of life during olaparib maintenance therapy in platinum-sensitive relapsed serous ovarian cancer.
British Journal of Cancer
, 115
(11)
pp. 1313-1320.
10.1038/bjc.2016.348.
|
|
Ledermann, JA;
Harter, P;
Gourley, C;
Friedlander, M;
Vergote, I;
Rustin, G;
Scott, C;
... Matulonis, U; + view all
(2016)
Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial.
The Lancet Oncology
, 17
(11)
pp. 1579-1589.
10.1016/S1470-2045(16)30376-X.
|
|
Lee, AJX;
Benamore, R;
Hofer, M;
Chitnis, M;
(2016)
Leptomeningeal carcinomatosis in non-small-cell lung cancer: initial response to erlotinib followed by relapse despite continuing radiological resolution of disease.
Oxford Medical Case Reports
, 2016
(9)
, Article omw069. 10.1093/omcr/omw069.
|
|
|
Lee, SM;
Falzon, M;
Blackhall, F;
Spicer, J;
Nicolson, M;
Chaudhuri, A;
Middleton, G;
... Hackshaw, A; + view all
(2016)
Randomized Prospective Biomarker Trial of ERCC1 for Comparing Platinum and Nonplatinum Therapy in Advanced Non-Small-Cell Lung Cancer: ERCC1 Trial (ET).
Journal of Clinical Oncology
, 35
(4)
pp. 402-411.
10.1200/JCO.2016.68.1841.
|
|
|
Lemay, J-F;
Marguerat, S;
Larochelle, M;
Liu, X;
Van Nues, R;
Hunyadkurti, J;
Hoque, M;
... Bachand, F; + view all
(2016)
The Nrd1-like protein Seb1 coordinates cotranscriptional 3′ end processing and polyadenylation site selection.
Genes and Development
, 30
(13)
pp. 1558-1572.
10.1101/gad.280222.116.
|
|
Lemech, CR;
Ensell, L;
Paterson, JC;
Eminowicz, G;
Lowe, H;
Arora, R;
Arkenau, H-T;
... Kristeleit, RS; + view all
(2016)
Enumeration and Molecular Characterisation of Circulating Tumour Cells in Endometrial Cancer.
Oncology
, 91
(1)
pp. 48-54.
10.1159/000445999.
|
|
Levine, AP;
Pontikos, N;
Schiff, ER;
Jostins, L;
Speed, D;
NIDDK Inflammatory Bowel Disease Genetics Consortium, .;
Lovat, LB;
... Segal, AW; + view all
(2016)
Genetic Complexity of Crohn’s Disease in Two Large Ashkenazi Jewish Families.
Gastroenterology
, 151
(4)
pp. 698-709.
10.1053/j.gastro.2016.06.040.
|
|
|
Lewis, J;
Breeze, CE;
Charlesworth, J;
Maclaren, OJ;
Cooper, J;
(2016)
Where next for the reproducibility agenda in computational biology?
BMC Systems Biology
, 10
, Article 52. 10.1186/s12918-016-0288-x.
|
|
Libertini, E;
Heath, SC;
Hamoudi, RA;
Gut, M;
Ziller, MJ;
Czyz, A;
Ruotti, V;
... Beck, S; + view all
(2016)
Information recovery from low coverage whole-genome bisulfite sequencing.
Nature Communications
, 7
, Article 11306. 10.1038/ncomms11306.
|
|
|
Libertini, E;
Heath, SC;
Hamoudi, RA;
Gut, M;
Ziller, MJ;
Herrero, J;
Czyz, A;
... Beck, S; + view all
(2016)
Saturation analysis for whole-genome bisulfite sequencing data.
[Letter].
Nature Biotechnology
, 34
(7)
pp. 691-693.
10.1038/nbt.3524.
|
|
Lidove, O;
Barbey, F;
Niu, DM;
Brand, E;
Nicholls, K;
Bizjajeva, S;
Hughes, DA;
(2016)
Fabry in the older patient: Clinical consequences and possibilities for treatment.
Molecular Genetics and Metabolism
, 118
(4)
pp. 319-325.
10.1016/j.ymgme.2016.05.009.
|
|
|
Little, AM;
Green, A;
Harvey, J;
Hemmatpour, S;
Latham, K;
Marsh, SG;
Poulton, K;
(2016)
BSHI Guideline: HLA matching and donor selection for haematopoietic progenitor cell transplantation.
International Journal of Immunogenetics
, 43
(5)
pp. 263-286.
10.1111/iji.12282.
|
|
Lloyd, AJ;
Gallop, K;
Ali, S;
Hughes, D;
MacCulloch, A;
(2016)
Social preference weights for treatments in Fabry disease in the UK: a discrete choice experiment.
Current Medical Research and Opinion
, 33
(1)
pp. 23-29.
10.1080/03007995.2016.1232704.
|
|
|
Lopez-Guadamillas, E;
Fernandez-Marcos, PJ;
Pantoja, C;
Muñoz-Martin, M;
MartÃnez, D;
Gómez-López, G;
Campos-Olivas, R;
... Serrano, M; + view all
(2016)
p21(Cip1) plays a critical role in the physiological adaptation to fasting through activation of PPARα.
Sci Rep
, 6
, Article 34542. 10.1038/srep34542.
|
|
|
Lopez-Guadamillas, E;
Muñoz-Martin, M;
Martinez, S;
Pastor, J;
Fernandez-Marcos, PJ;
Serrano, M;
(2016)
PI3Kα inhibition reduces obesity in mice.
Aging
, 8
(11)
pp. 2747-2753.
10.18632/aging.101075.
|
|
|
Lorente, D;
Omlin, A;
Zafeiriou, Z;
Nava-Rodrigues, D;
Pérez-López, R;
Pezaro, C;
Mehra, N;
... de Bono, J; + view all
(2016)
Castration-Resistant Prostate Cancer Tissue Acquisition From Bone Metastases for Molecular Analyses.
Clinical Genitourinary Cancer
, 14
(6)
pp. 485-493.
10.1016/j.clgc.2016.04.016.
|
|
|
Lubbe, SJ;
Escott-Price, V;
Gibbs, JR;
Nalls, MA;
Bras, J;
Price, TR;
Nicolas, A;
... for International Parkinson’s Disease Genomics Consortium, .; + view all
(2016)
Additional rare variant analysis in Parkinson's disease cases with and without known pathogenic mutations: evidence for oligogenic inheritance.
Human Molecular Genetics
, 25
(24)
pp. 5483-5489.
10.1093/hmg/ddw348.
|
|
M
|
Maciocia, N;
Wechalekar, A;
Yong, K;
(2016)
Monoclonal gammopathy of undetermined significance and smoldering myeloma (SMM): a practical guide to management.
Hematological Oncology
, 35
(4)
pp. 432-439.
10.1002/hon.2345.
|
|
|
Maciocia, PM;
Wawrzyniecka, P;
Philip, B;
Akarca, A;
Marafioti, T;
Pule, MA;
(2016)
Targeting the TCR beta-constant region for specific immunotherapy of T-cell malignancies.
Presented at: Conference on Changing the Face of Modern Medicine - Stem Cells and Gene Therapy, Florence, ITALY.
|
|
|
Maclean, JD;
(2016)
Advanced radiation therapies for meningioma.
Doctoral thesis , UCL (University College London).
|
|
|
Majumder, B;
Koganti, S;
Lowdell, MW;
Rakhit, RD;
(2016)
Intracoronary platelet and monocyte activation status within platelet-monocyte complexes are determinants of inflammation in ST elevation myocardial infarction1.
Clinical Hemorheology and Microcirculation
, 64
(1)
pp. 35-46.
10.3233/CH-162040.
|
|
|
Mak, G;
Moschetta, M;
Arkenau, H-T;
(2016)
Reporting incidental germline variants in the context of day-to-day somatic genomic profiling.
Annals of Oncology
, 27
(5)
pp. 758-759.
10.1093/annonc/mdw078.
|
|
Malhotra, K;
Butler, JS;
Yu, HM;
Selvadurai, S;
D'Sa, S;
Rabin, N;
Kyriakou, C;
... Molloy, S; + view all
(2016)
Spinal disease in myeloma: cohort analysis at a specialist spinal surgery centre indicates benefit of early surgical augmentation or bracing.
BMC Cancer
, 16
, Article 444. 10.1186/s12885-016-2495-7.
|
|
|
Mandair, D;
Vesely, C;
Ensell, L;
Lowe, H;
Spanswick, V;
Hartley, JA;
Caplin, ME;
(2016)
A comparison of CellCollector with CellSearch in patients with neuroendocrine tumours.
Endocrine-Related Cancer
, 23
(10)
L29-L32.
10.1530/ERC-16-0201.
|
|
Marina, NM;
Smeland, S;
Bielack, SS;
Bernstein, M;
Jovic, G;
Krailo, MD;
Hook, JM;
... Whelan, JS; + view all
(2016)
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial.
The Lancet Oncology
, 17
(10)
pp. 1396-1408.
10.1016/S1470-2045(16)30214-5.
|
|
|
Maslin, D;
Gounaris, I;
Ng, K;
Corrie, P;
(2016)
Lesson of the month 2: Cauda equina in Cushing’s syndrome.
Clinical Medicine
, 16
(1)
pp. 88-90.
10.7861/clinmedicine.16-1-88.
|
|
|
Mateo, J;
Moreno, V;
Gupta, A;
Kaye, SB;
Dean, E;
Middleton, MR;
Friedlander, M;
... Molife, LR; + view all
(2016)
An Adaptive Study to Determine the Optimal Dose of the Tablet Formulation of the PARP Inhibitor Olaparib.
Targeted Oncology
, 11
(3)
pp. 401-415.
10.1007/s11523-016-0435-8.
|
|
Maughan, E;
Lesage, F;
Butler, CR;
Hynds, RE;
Hewitt, R;
Janes, SM;
Deprest, JA;
(2016)
Airway tissue engineering for congenital laryngotracheal disease.
Seminars in Pediatric Surgery
, 25
(3)
pp. 186-190.
10.1053/j.sempedsurg.2016.02.012.
|
|
Maybury, B;
Cook, G;
Pratt, G;
Yong, K;
Ramasamy, K;
(2016)
Augmenting Autologous Stem Cell Transplantation to Improve Outcomes in Myeloma.
Biology of Blood and Marrow Transplantation
, 22
(11)
pp. 1926-1937.
10.1016/j.bbmt.2016.06.004.
|
|
|
McCourt, O;
Heinrich, M;
Fisher, A;
Paton, B;
Beeken, R;
Hackshaw, A;
Rismani, A;
... Yong, K; + view all
(2016)
Use of an 'adapted Zelen' design in a randomised controlled trial of a physiotherapist-led exercise intervention in patients with myeloma.
Presented at: th European Congress of the European Region of the World Confederation of Physical Therapy (ER-WCPT), Liverpool, UK.
|
|
McGregor, L;
Von Wagner, C;
Atkin, W;
Kralj-Hans, I;
Halloran, S;
Handley, G;
Logan, R;
... Wardle, J; + view all
(2016)
Reducing the social gradient in uptake of the NHS Colorectal Cancer Screening Programme using a narrative-based information leaflet: a cluster-randomised trial.
Gastroenterology Research and Practice
, 2016
, Article 3670150. 10.1155/2016/3670150.
|
|
Meghini, F;
Martins, T;
Tait, X;
Fujimitsu, K;
Yamano, H;
Glover, DM;
Kimata, Y;
(2016)
Targeting of Fzr/Cdh1 for timely activation of the APC/C at the centrosome during mitotic exit.
Nature Communications
, 7
, Article 12607. 10.1038/ncomms12607.
|
|
|
Menezes, S;
Melandri, D;
Anselmi, G;
Perchet, T;
Loschko, J;
Dubrot, J;
Patel, R;
... Guermonprez, P; + view all
(2016)
The Heterogeneity of Ly6C(hi) Monocytes Controls Their Differentiation into iNOS(+) Macrophages or Monocyte-Derived Dendritic Cells.
Immunity
, 45
(6)
pp. 1205-1218.
10.1016/j.immuni.2016.12.001.
|
 |
|
Menger, L;
Sledzinska, A;
Bergerhoff, K;
Vargas, FA;
Smith, J;
Poirot, L;
Pule, M;
... Quezada, SA; + view all
(2016)
TALEN-Mediated Inactivation of PD-1 in Tumor-Reactive Lymphocytes Promotes Intratumoral T-cell Persistence and Rejection of Established Tumors.
Cancer Research
, 76
(8)
pp. 2087-2093.
10.1158/0008-5472.CAN-15-3352.
|
|
|
Meys, R;
Purdie, KJ;
de Koning, MNC;
Quint, KD;
Little, A-M;
Baker, F;
Francis, N;
... Bunker, CB; + view all
(2016)
HLA Immunogenotype Determines Persistent Human Papillomavirus Virus Infection in HIV-Infected Patients Receiving Antiretroviral Treatment.
Journal of Infectious Diseases
, 213
(11)
pp. 1717-1724.
10.1093/infdis/jiw038.
|
|
Miller, RE;
Brown, NE;
Speirs, A;
Shaw, HM;
Adeleke, S;
Gougis, P;
Bennett, P;
... Kristeleit, RS; + view all
(2016)
The use of next generation sequencing (NGS) to guide patient selection for phase 1 clinical trials.
Annals of Oncology
, 27
(Suppl 6)
pp. 114-135.
10.1093/annonc/mdw368.44.
|
|
Miller, RE;
Ledermann, JA;
(2016)
The status of poly(adenosine diphosphate-ribose) polymerase (PARP) inhibitors in ovarian cancer, part 1: olaparib.
Clinical Advances in Hematology & Oncology
, 14
(8)
pp. 619-627.
|
|
|
Miller, RE;
Ledermann, JA;
(2016)
The status of poly(adenosine diphosphate-ribose) polymerase (PARP) inhibitors in ovarian cancer, part 2: extending the scope beyond olaparib and BRCA1/2 mutations.
Clinical Advances in Hematology & Oncology
, 14
(9)
pp. 704-711.
|
|
Mirza, MR;
Monk, BJ;
Herrstedt, J;
Oza, AM;
Mahner, S;
Redondo, A;
Fabbro, M;
... ENGOT-OV16/NOVA Investigators; + view all
(2016)
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer.
The New England Journal of Medicine
, 375
(22)
pp. 2154-2164.
10.1056/NEJMoa1611310.
|
|
Mock, U;
Nickolay, L;
Philip, B;
Cheung, GW;
Zhan, H;
Johnston, IC;
Kaiser, AD;
... Qasim, W; + view all
(2016)
Automated manufacturing of chimeric antigen receptor T cells for adoptive immunotherapy using CliniMACS prodigy.
Cytotherapy
, 18
(8)
pp. 1002-1011.
10.1016/j.jcyt.2016.05.009.
|
N
|
Nathwani, AC;
Down, JF;
Goldstone, J;
Yassin, J;
Dargan, PI;
Virchis, A;
Gent, N;
... Harrison, JD; + view all
(2016)
Polonium-210 poisoning: a first-hand account.
The Lancet
, 388
(10049)
pp. 1075-1080.
10.1016/S0140-6736(16)00144-6.
|
|
|
Nile, DL;
Rae, C;
Hyndman, IJ;
Gaze, MN;
Mairs, RJ;
(2016)
An evaluation in vitro of PARP-1 inhibitors, rucaparib and olaparib, as radiosensitisers for the treatment of neuroblastoma.
BMC Cancer
, 16
(1)
, Article 621. 10.1186/s12885-016-2656-8.
|
|
|
Nordin, S;
Kozor, R;
Bulluck, H;
Castelletti, S;
Rosmini, S;
Abdel-Gadir, A;
Baig, S;
... Moon, JC; + view all
(2016)
Cardiac Fabry Disease With Late Gadolinium Enhancement Is a Chronic Inflammatory Cardiomyopathy.
[Letter].
Journal of the American College of Cardiology
, 68
(15)
pp. 1707-1708.
10.1016/j.jacc.2016.07.741.
|
|
O
|
O'Connor, JP;
Aboagye, EO;
Adams, JE;
Aerts, HJ;
Barrington, SF;
Beer, AJ;
Boellaard, R;
... Waterton, JC; + view all
(2016)
Imaging biomarker roadmap for cancer studies.
Nat Rev Clin Oncol
10.1038/nrclinonc.2016.162.
(In press).
|
|
O'Neill, AT;
Hockey, J;
O'Brien, P;
Williams, A;
Morris, TP;
Khan, T;
Hardwick, E;
(2016)
Knowledge of pelvic floor problems: a study of third trimester, primiparous women.
International Urogynecology Journal
, 28
(1)
pp. 125-129.
10.1007/s00192-016-3087-4.
|
|
Ohs, I;
van den Broek, M;
Nussbaum, K;
Munz, C;
Arnold, SJ;
Quezada, SA;
Tugues, S;
(2016)
Interleukin-12 bypasses common gamma-chain signalling in emergency natural killer cell lymphopoiesis.
Nature Communications
, 7
, Article 13708. 10.1038/ncomms13708.
|
|
|
Okkenhaug, K;
Graupera, M;
Vanhaesebroeck, B;
(2016)
Targeting PI3K in Cancer: Impact on Tumor Cells, Their Protective Stroma, Angiogenesis, and Immunotherapy.
Cancer Discovery
, 6
(10)
pp. 1090-1105.
10.1158/2159-8290.CD-16-0716.
|
|
|
Oktay, Y;
Ulgen, E;
Can, O;
Akyerli, CB;
Yuksel, S;
Erdemgil, Y;
Durasi, IM;
... Ozduman, K; + view all
(2016)
IDH-mutant glioma specific association of rs55705857 located at 8q24.21 involves MYC deregulation.
Scientific Reports
, 6
, Article 27569. 10.1038/srep27569.
|
|
|
Olsson, M;
Beck, S;
Kogner, P;
Martinsson, T;
Carén, H;
(2016)
Genome-wide methylation profiling identifies novel methylated genes in neuroblastoma tumors.
Epigenetics
pp. 1-11.
10.1080/15592294.2016.1138195.
|
P
|
Parhizkar, M;
Reardon, PJ;
Knowles, JC;
Browning, RJ;
Stride, E;
Pedley, BR;
Harker, AH;
(2016)
Electrohydrodynamic encapsulation of cisplatin in poly (lactic-co-glycolic acid) nanoparticles for controlled drug delivery.
Nanomedicine
, 12
(7)
pp. 1919-1929.
10.1016/j.nano.2016.05.005.
|
|
Pataillot-Meakin, T;
Pillay, N;
Beck, S;
(2016)
3-methylcytosine in cancer: an underappreciated methyl lesion?
Epigenomics
, 8
(4)
pp. 451-454.
10.2217/epi.15.121.
|
|
Patel, B;
Kirkwood, AA;
Dey, A;
Marks, DI;
McMillan, AK;
Menne, TF;
Micklewright, L;
... Fielding, AK; + view all
(2016)
Pegylated-asparaginase during induction therapy for adult acute lymphoblastic leukaemia: toxicity data from the UKALL14 trial.
Leukemia
10.1038/leu.2016.219.
|
|
Paul, DS;
Teschendorff, AE;
Dang, MA;
Lowe, R;
Hawa, MI;
Ecker, S;
Beyan, H;
... Leslie, RD; + view all
(2016)
Increased DNA methylation variability in type 1 diabetes across three immune effector cell types.
Nature Communications
, 7
, Article 13555. 10.1038/ncomms13555.
|
|
Pedroza-Pacheco, I;
Shah, D;
Domogala, A;
Luevano, M;
Blundell, M;
Jackson, N;
Thrasher, A;
... Saudemont, A; + view all
(2016)
Regulatory T cells inhibit CD34+ cell differentiation into NK cells by blocking their proliferation.
Scientific Reports
, 6
, Article 22097. 10.1038/srep22097.
|
|
|
Peltzer, N;
Darding, M;
Walczak, H;
(2016)
Holding RIPK1 on the Ubiquitin Leash in TNFR1 Signaling.
Trends in Cell Biology
, 26
(6)
pp. 445-461.
10.1016/j.tcb.2016.01.006.
|
|
|
Perna, C;
Eminowicz, G;
Asghar, U;
Imseeh, G;
Kirkwood, A;
Mitra, A;
Arora, R;
... McCormack, M; + view all
(2016)
Uterine carcinosarcoma: a retrospective clinical cohort analysis.
Presented at: ESMO 2016: 41st ESMO Congress, Copenhagen, Denmark.
|
|
Pescatore, A;
Esposito, E;
Draber, P;
Walczak, H;
Ursini, MV;
(2016)
NEMO regulates a cell death switch in TNF signaling by inhibiting recruitment of RIPK3 to the cell death-inducing complex II.
Cell Death and Disease
, 7
(ARTN e23)
10.1038/cddis.2016.245.
|
|
|
Pignatelli, M;
Vilella, AJ;
Muffato, M;
Gordon, L;
White, S;
Flicek, P;
Herrero, J;
(2016)
ncRNA orthologies in the vertebrate lineage.
Database (Oxford)
, 2016
, Article bav127. 10.1093/database/bav127.
|
|
|
Pillinger, G;
Loughran, NV;
Piddock, RE;
Shafat, MS;
Zaitseva, L;
Abdul-Aziz, A;
Lawes, MJ;
... Rushworth, SA; + view all
(2016)
Targeting PI3Kδ and PI3Kγ signalling disrupts human AML survival and bone marrow stromal cell mediated protection.
Oncotarget
, 7
(26)
pp. 39784-39795.
10.18632/oncotarget.9289.
|
|
|
Plesner, T;
Arkenau, H-T;
Gimsing, P;
Krejcik, J;
Lemech, C;
Minnema, MC;
Lassen, U;
... Richardson, PG; + view all
(2016)
Phase 1/2 study of daratumumab, lenalidomide, and dexamethasone for relapsed multiple myeloma.
Blood
, 128
(14)
pp. 1821-1828.
10.1182/blood-2016-07-726729.
|
|
|
Popat, R;
Brown, SR;
Flanagan, L;
Hall, A;
Gregory, W;
Kishore, B;
Streetly, M;
... Myeloma UK Early Phase Clinical Trial Network, .; + view all
(2016)
Bortezomib, thalidomide, dexamethasone, and panobinostat for patients with relapsed multiple myeloma (MUK-six): a multicentre, open-label, phase 1/2 trial.
The Lancet Haematology
, 3
(12)
e572-e580.
10.1016/S2352-3026(16)30165-X.
|
|
|
Pourcet, B;
Gage, MC;
León, TE;
Waddington, KE;
Pello, OM;
Steffensen, KR;
Castrillo, A;
... Pineda-Torra, I; + view all
(2016)
The nuclear receptor LXR modulates interleukin-18 levels in macrophages through multiple mechanisms.
Scientific Reports
, 6
, Article 25481. 10.1038/srep25481.
|
|
|
Prasanna, KS;
Goel, A;
Amirtharaj, GJ;
Ramachandran, A;
Balasubramanian, KA;
Mackie, I;
Zachariah, U;
... Eapen, CE; + view all
(2016)
Plasma von Willebrand factor levels predict in-hospital survival in patients with acute-on-chronic liver failure.
Indian Journal of Gastroenterology
, 35
(6)
pp. 432-440.
10.1007/s12664-016-0708-2.
|
|
Pugh, G;
Gravestock, HL;
Hough, RE;
King, WM;
Wardle, J;
Fisher, A;
(2016)
Health Behavior Change Interventions for Teenage and Young Adult Cancer Survivors: A Systematic Review.
Journal of Adolescent and Young Adult Oncology
, 5
(2)
pp. 91-105.
10.1089/jayao.2015.0042.
|
|
Pugh, SA;
Bowers, M;
Ball, A;
Falk, S;
Finch-Jones, M;
Valle, JW;
O'Reilly, DA;
... Primrose, JN; + view all
(2016)
Patterns of progression, treatment of progressive disease and post-progression survival in the New EPOC study.
British Journal of Cancer
, 115
(4)
pp. 420-424.
10.1038/bjc.2016.208.
|
|
Q
|
Quaglia, A;
Alves, VA;
Balabaud, C;
Bhathal, PS;
Bioulac-Sage, P;
Crawford, JM;
Dhillon, AP;
... van Leeuwen, DJ; + view all
(2016)
Role of aetiology in the progression, regression, and parenchymal remodelling of liver disease: implications for liver biopsy interpretation.
Histopathology
, 68
(7)
pp. 953-967.
10.1111/his.12957.
|
|
Quek, L;
Otto, GW;
Garnett, C;
Lhermitte, L;
Karamitros, D;
Stoilova, B;
Lau, I-J;
... Vyas, P; + view all
(2016)
Genetically distinct leukemic stem cells in human CD34(-) acute myeloid leukemia are arrested at a hemopoietic precursor-like stage.
Journal of Experimental Medicine
, 213
(8)
pp. 1513-1535.
10.1084/jem.20151775.
|
R
|
Raab, MS;
Cavo, M;
Delforge, M;
Driessen, C;
Fink, L;
Flinois, A;
Gonzalez-McQuire, S;
... Yong, K; + view all
(2016)
Multiple myeloma: practice patterns across Europe.
British Journal of Haematology
, 175
(1)
pp. 66-76.
10.1111/bjh.14193.
|
|
|
Raine, R;
Duffy, SW;
Wardle, J;
Solmi, F;
Morris, S;
Howe, R;
Kralj-Hans, I;
... Atkin, W; + view all
(2016)
Impact of general practice endorsement on the social gradient in uptake in bowel cancer screening.
British Journal of Cancer
, 114
pp. 321-326.
10.1038/bjc.2015.413.
|
|
Raine, R;
Moss, SM;
von Wagner, C;
Atkin, W;
Hans, IK;
Howe, R;
Solmi, F;
... Duffy, SW; + view all
(2016)
A national cluster-randomised controlled trial to examine the effect of enhanced reminders on the socioeconomic gradient in uptake in bowel cancer screening.
British Journal of Cancer
, 115
(12)
pp. 1479-1486.
10.1038/bjc.2016.365.
|
|
Ramasawmy, R;
Johnson, SP;
Roberts, TA;
Stuckey, DJ;
David, AL;
Pedley, RB;
Lythgoe, MF;
... Walker-Samuel, S; + view all
(2016)
Monitoring the Growth of an Orthotopic Tumour Xenograft Model: Multi-Modal Imaging Assessment with Benchtop MRI (1T), High-Field MRI (9.4T), Ultrasound and Bioluminescence.
PLoS One
, 11
(5)
, Article e0156162. 10.1371/journal.pone.0156162.
|
|
|
Reading, JL;
Quezada, SA;
(2016)
Too Much of a Good Thing? Chronic IFN Fuels Resistance to Cancer Immunotherapy.
Immunity
, 45
(6)
pp. 1181-1183.
10.1016/j.immuni.2016.12.004.
|
|
Reyal, Y;
Kayani, I;
Bloor, AJC;
Fox, CP;
Chakraverty, R;
Sjursen, A-M;
Fielding, AK;
... Peggs, KS; + view all
(2016)
Impact of Pretransplantation F-18-Fluorodeoxyglucose-Positron Emission Tomography on Survival Outcomes after T Cell-Depleted Allogeneic Transplantation for Hodgkin Lymphoma.
Biology of Blood and Marrow Transplantation
, 22
(7)
pp. 1234-1241.
10.1016/j.bbmt.2016.03.034.
|
|
|
Richardson, SE;
(2016)
Modeling TEL-AML1 childhood acute lymphoblastic leukaemia using human pluripotent stem cells.
Doctoral thesis , UCL (University College London).
|
|
Riquelme, JA;
Westermeier, F;
Hall, AR;
Vicencio, JM;
Pedrozo, Z;
Ibacache, M;
Fuenzalida, B;
... Lavandero, S; + view all
(2016)
Dexmedetomidine protects the heart against ischemia-reperfusion injury by an endothelial eNOS/NO dependent mechanism.
Pharmacological Research
, 103
pp. 318-327.
10.1016/j.phrs.2015.11.004.
|
|
Roddie, C;
(2016)
Targeting interference of CTLA-4 co-inhibition to tumour specific T cells to enhance activity and reduce toxicity.
Doctoral thesis , UCL (University College London).
|
|
Rohman, PJ;
Scott, E;
Richfield, L;
Ramaswami, U;
Hughes, DA;
(2016)
Pregnancies and associated events in women receiving Enzyme Replacement Therapy for late onset Glycogen Storage Disease Type II (Pompe disease).
Journal of Obstetrics and Gynaecology Research
, 42
(10)
pp. 1263-1271.
10.1111/jog.13055.
|
|
Rooshenas, L;
Elliott, D;
Wade, J;
Jepson, M;
Paramasivan, S;
Strong, S;
Wilson, C;
... POUT study group; + view all
(2016)
Conveying Equipoise during Recruitment for Clinical Trials: Qualitative Synthesis of Clinicians' Practices across Six Randomised Controlled Trials.
PLoS Med
, 13
(10)
, Article e1002147. 10.1371/journal.pmed.1002147.
|
|
|
Rosenthal, R;
McGranahan, N;
Herrero, J;
Taylor, BS;
Swanton, C;
(2016)
deconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution.
Genome Biol
, 17
(1)
p. 31.
10.1186/s13059-016-0893-4.
|
|
Rothermundt, C;
Seddon, BM;
Dileo, P;
Strauss, SJ;
Coleman, J;
Briggs, TW;
Haile, SR;
(2016)
Follow-up practices for high-grade extremity Osteosarcoma.
BMC Cancer
, 16
, Article 301. 10.1186/s12885-016-2333-y.
|
|
|
Rowley, MI;
Coolen, ACC;
Vojnovic, B;
Barber, PR;
(2016)
Correction: Robust Bayesian fluorescence lifetime estimation, decay model selection and instrument response determination for low-intensity FLIM imaging.
PLoS ONE
, 11
(8)
, Article e0162224. 10.1371/journal.pone.0162224.
|
|
|
Rowley, MI;
Coolen, ACC;
Vojnovic, B;
Barber, PR;
(2016)
Robust Bayesian Fluorescence Lifetime Estimation, Decay Model Selection and Instrument Response Determination for Low-Intensity FLIM Imaging.
PLoS One
, 11
(6)
, Article e0158404. 10.1371/journal.pone.0158404.
|
|
S
|
Salvi, S;
Casadio, V;
Conteduca, V;
Lolli, C;
Gurioli, G;
Martignano, F;
Schepisi, G;
... De Giorgi, U; + view all
(2016)
Circulating AR copy number and outcome to enzalutamide in docetaxel-treated metastatic castration-resistant prostate cancer.
Oncotarget
, 7
(25)
pp. 37839-37845.
10.18632/oncotarget.9341.
|
|
|
Santos e Sousa, P;
Ward, S;
Lomas, C;
Conlan, T;
Shorrock, H;
Means, TK;
Plagnol, V;
... Bennett, CL; + view all
(2016)
A systems immunology approach to GVHD defines skin-autonomous control of donor T cells.
Presented at: 2016 Keystone Symposia Conference: Immunity in Skin Development, Homeostasis and Disease, 28 February - 2 March 2016, Tahoe City, California, USA, Granlibakken, CA.
|
|
|
Savas, P;
Teo, ZL;
Lefevre, C;
Flensburg, C;
Caramia, F;
Alsop, K;
Mansour, M;
... Loi, S; + view all
(2016)
The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program "CASCADE".
PLoS Medicine
, 13
(12)
, Article e1002204. 10.1371/journal.pmed.1002204.
|
|
|
Scelo, G;
Hofmann, JN;
Banks, RE;
Bigot, P;
Bhatt, RS;
Cancel-Tassin, G;
Chew, SK;
... Chanock, SJ; + view all
(2016)
International cancer seminars: a focus on kidney cancer.
Annals of Oncology
, 27
(8)
pp. 1382-1385.
10.1093/annonc/mdw186.
|
|
|
Scheipl, S;
Barnard, M;
Cottone, L;
Jorgensen, M;
Drewry, DH;
Zuercher, WJ;
Turlais, F;
... Flanagan, AM; + view all
(2016)
EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen.
J Pathol
, 239
(3)
pp. 320-334.
10.1002/path.4729.
|
|
|
Seifert, W;
Posor, Y;
Schu, P;
Stenbeck, G;
Mundlos, S;
Klaassen, S;
Nuernberg, P;
... Kuehnisch, J; + view all
(2016)
The progressive ankylosis protein ANK facilitates clathrin- and adaptor-mediated membrane traffic at the trans-Golgi network-to-endosome interface.
Human Molecular Genetics
, 25
(17)
pp. 3836-3848.
10.1093/hmg/ddw230.
|
|
|
Sekine, S;
Yoshida, H;
Jansen, M;
Kushima, R;
(2016)
The Japanese Viewpoint on the Histopathology of Early Gastric Cancer.
Stem Cells, Pre-neoplasia, and Early Cancer of the Upper Gastrointestinal Tract
, 908
pp. 331-346.
10.1007/978-3-319-41388-4_16.
|
|
Sellar, RS;
Fraser, L;
Khwaja, A;
Gale, RE;
Marafioti, T;
Akarca, A;
Hubank, M;
... Linch, DC; + view all
(2016)
Cell cycle status in AML blast cells from peripheral blood, bone marrow aspirates and trephines and implications for biological studies and treatment.
British Journal of Haematology
, 174
(2)
pp. 275-279.
10.1111/bjh.14055.
|
|
Sharief, LAT;
Lawrie, AS;
Mackie, IJ;
Halimeh, S;
Kappert, G;
Smith, C;
Peyvandi, F;
(2016)
Plasma factor XIII level variations during menstrual cycle.
Blood Coagulation & Fibrinolysis
, 27
(7)
pp. 786-790.
10.1097/MBC.0000000000000491.
|
|
Sharma, RA;
Plummer, R;
Stock, JK;
Greenhalgh, TA;
Ataman, O;
Kelly, S;
Clay, R;
... Wedge, SR; + view all
(2016)
Clinical development of new drug-radiotherapy combinations.
NATURE REVIEWS CLINICAL ONCOLOGY
, 13
(10)
pp. 627-642.
10.1038/nrclinonc.2016.79.
|
|
|
Shiao, J;
Winter, H;
Sharma, RA;
(2016)
Landmark study raises the bar for interventional oncology.
Future Oncology
, 12
(15)
pp. 1747-1749.
10.2217/fon-2016-0212.
|
|
Sivabalasingham, S;
(2016)
Biological and Clinical Evaluation of Intensity Modulated Radiotherapy for Brain Tumours.
Doctoral thesis , UCL (University College London).
|
|
Sivakumaran, S;
Henderson, S;
Ward, S;
Santos E Sousa, P;
Manzo, T;
Zhang, L;
Conlan, T;
... Bennett, CL; + view all
(2016)
Depletion of CD11c(+) cells in the CD11c.DTR model drives expansion of unique CD64(+) Ly6C(+) monocytes that are poised to release TNF-α.
European Journal of Immunology
, 46
(1)
pp. 192-203.
10.1002/eji.201545789.
|
|
|
Sive, JI;
Feber, A;
Smith, D;
Quinn, J;
Beck, S;
Yong, K;
(2016)
Global hypomethylation in myeloma is associated with poor prognosis.
British Journal of Haematology
, 172
(3)
pp. 473-475.
10.1111/bjh.13506.
|
|
Skinner, BM;
Sargent, CA;
Churcher, C;
Hunt, T;
Herrero, J;
Loveland, JE;
Dunn, M;
... Tyler-Smith, C; + view all
(2016)
The pig X and Y Chromosomes: structure, sequence, and evolution.
Genome Research
, 26
(1)
pp. 130-139.
10.1101/gr.188839.114.
|
|
|
Smith, D;
Yong, K;
(2016)
Advances in understanding prognosis in myeloma.
British Journal of Haematology
, 175
(3)
pp. 367-380.
10.1111/bjh.14304.
|
|
Soria, JC;
Gan, HK;
Blagden, SP;
Plummer, R;
Arkenau, HT;
Ranson, M;
Evans, TRJ;
... Millward, M; + view all
(2016)
A phase I, pharmacokinetic and pharmacodynamic study of GSK2256098, a focal adhesion kinase inhibitor, in patients with advanced solid tumors.
Annals of Oncology
, 27
(12)
pp. 2268-2274.
10.1093/annonc/mdw427.
|
|
|
Soriano, EV;
Ivanova, ME;
Fletcher, G;
Riou, P;
Knowles, PP;
Barnouin, K;
Purkiss, A;
... McDonald, NQ; + view all
(2016)
aPKC Inhibition by Par3 CR3 Flanking Regions Controls Substrate Access and Underpins Apical-Junctional Polarization.
Developmental Cell
, 38
(4)
pp. 384-398.
10.1016/j.devcel.2016.07.018.
|
|
|
Stavrou, M;
(2016)
CAR Gene Transfer to Generate Antigen Specific Regulators.
Doctoral thesis , UCL (University College London).
|
|
Steele, CD;
(2016)
Statistical issues surrounding the analysis of forensic low-template DNA samples.
Doctoral thesis , UCL (University College London).
|
|
Steele, CD;
Greenhalgh, M;
Balding, DJ;
(2016)
Evaluation of low-template DNA profiles using peak heights.
Statistical Applications in Genetics and Molecular Biology
, 15
(5)
pp. 431-445.
10.1515/sagmb-2016-0038.
|
|
Stein, RC;
Dunn, JA;
Bartlett, JMS;
Campbell, AF;
Marshall, A;
Hall, P;
Rooshenas, L;
+ view all
(2016)
OPTIMA: a randomised feasibility study of personalised care in the treatment of women with early breast cancer.
(Health Technology Assessment
20(10)
, pp. pp. 1-202
).
National Institute of Health Research: UK.
|
|
|
Stunnenberg, HG;
Abrignani, S;
Adams, D;
de Almeida, M;
Altucci, L;
Amin, V;
Amit, I;
... Kim, SC; + view all
(2016)
The International Human Epigenome Consortium: A Blueprint for Scientific Collaboration and Discovery.
Cell
, 167
(5)
pp. 1145-1149.
10.1016/j.cell.2016.11.007.
|
|
Swanton, C;
Govindan, R;
(2016)
Clinical Implications of Genomic Discoveries in Lung Cancer.
New England Journal of Medicine
, 374
(19)
pp. 1864-1873.
10.1056/NEJMra1504688.
|
|
|
Szikriszt, B;
Poti, A;
Pipek, O;
Krzystanek, M;
Kanu, N;
Molnar, J;
Ribli, D;
... Szuts, D; + view all
(2016)
A comprehensive survey of the mutagenic impact of common cancer cytotoxics.
Genome Biology
, 17
, Article 99. 10.1186/s13059-016-0963-7.
|
|
T
|
Taher, AT;
Porter, JB;
Kattamis, A;
Viprakasit, V;
Cappellini, MD;
(2016)
Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with nontransfusion-dependent thalassemia syndromes.
Drug Design, Development and Therapy
, 10
pp. 4073-4078.
10.2147/DDDT.S117080.
|
|
|
Taieb, J;
Balogoun, R;
Le Malicot, K;
Tabernero, J;
Mini, E;
Folprecht, G;
Van Laethem, JL;
... PETACC8 investigators, .; + view all
(2016)
Adjuvant FOLFOX +/- cetuximab in full RAS and BRAF wildtype stage III colon cancer patients.
Annals of Oncology
10.1093/annonc/mdw687.
(In press).
|
|
Tape, CJ;
Ling, S;
Dimitriadi, M;
McMahon, KM;
Worboys, JD;
Leong, HS;
Norrie, IC;
... Jorgensen, C; + view all
(2016)
Oncogenic KRAS Regulates Tumor Cell Signaling via Stromal Reciprocation.
Cell
, 165
(4)
pp. 910-920.
10.1016/j.cell.2016.03.029.
|
|
|
Taylor, RM;
Fern, LA;
Aslam, N;
Whelan, JS;
(2016)
Direct access to potential research participants for a cohort study using a confidentiality waiver included in UK National Health Service legal statutes.
BMJ Open
, 6
(8)
, Article e011847. 10.1136/bmjopen-2016-011847.
|
|
|
Taylor, RM;
Solanki, A;
Aslam, N;
Whelan, JS;
Fern, LA;
(2016)
A participatory study of teenagers and young adults views on access and participation in cancer research.
European Journal of Oncology Nursing
, 20
pp. 156-164.
10.1016/j.ejon.2015.07.007.
|
|
|
Teh, CE;
Lalaoui, N;
Jain, R;
Policheni, AN;
Heinlein, M;
Alvarez-Diaz, S;
Sheridan, JM;
... Gray, DH; + view all
(2016)
Linear ubiquitin chain assembly complex coordinates late thymic T-cell differentiation and regulatory T-cell homeostasis.
Nat Commun
, 7
, Article 13353. 10.1038/ncomms13353.
|
|
|
Terrisse, AD;
Laurent, PA;
Garcia, C;
Gratacap, MP;
Vanhaesebroeck, B;
Sié, P;
Payrastre, B;
(2016)
The class I phosphoinositide 3-kinases α and β control antiphospholipid antibodies-induced platelet activation.
Thrombosis and Haemostasis
10.1160/TH15-08-0661.
|
|
Teschendorff, AE;
Zheng, SC;
Feber, A;
Yang, Z;
Beck, S;
Widschwendter, M;
(2016)
The multi-omic landscape of transcription factor inactivation in cancer.
Genome Medicine
, 8
, Article 89. 10.1186/s13073-016-0342-8.
|
|
|
Thomas, MR;
(2016)
The role of antibodies in acquired thrombotic thrombocytopenic purpura.
Doctoral thesis , UCL (University College London).
|
|
|
Thomas, S;
Straathof, K;
Himoudi, N;
Anderson, J;
Pule, M;
(2016)
An Optimized GD2-Targeting Retroviral Cassette for More Potent and Safer Cellular Therapy of Neuroblastoma and Other Cancers.
PLoS One
, 11
(3)
, Article e0152196. 10.1371/journal.pone.0152196.
|
|
|
Tosatto, A;
Sommaggio, R;
Kummerow, C;
Bentham, RB;
Blacker, TS;
Berecz, T;
Duchen, MR;
... Mammucari, C; + view all
(2016)
The mitochondrial calcium uniporter regulates breast cancer progression via HIF-1α.
EMBO Molecular Medicine
, 8
(5)
pp. 569-585.
10.15252/emmm.201606255.
|
|
|
Townsend, W;
Johnson, RJ;
Pottinger, BT;
Counsell, N;
Smith, P;
Chadwick, H;
Evans, K;
... Rudin, CE; + view all
(2016)
A phase II clinical trial of fludarabine and cyclophosphamide followed by thalidomide for angioimmunoblastic T-cell lymphoma. An NCRI clinical trial. CRUK number C17050/A5320.
Leukemia & Lymphoma
, 57
(9)
pp. 2232-2234.
10.3109/10428194.2015.1133814.
|
|
Tree, AC;
Harding, V;
Bhangu, A;
Krishnasamy, V;
Morton, D;
Stebbing, J;
Wood, BJ;
(2016)
The need for multidisciplinarity in specialist training to optimize future patient care.
Nature Reviews Clinical Oncology
, 14
pp. 508-517.
10.1038/nrclinonc.2016.185.
|
|
Tudzarova, S;
Mulholland, P;
Dey, A;
Stoeber, K;
Okorokov, AL;
Williams, GH;
(2016)
p53 controls CDC7 levels to reinforce G1 cell cycle arrest upon genotoxic stress.
Cell Cycle
, 15
(21)
pp. 2958-2972.
10.1080/15384101.2016.1231281.
|
|
Tummala, H;
Walne, AJ;
Williams, M;
Bockett, N;
Collopy, L;
Cardoso, S;
Ellison, A;
... Vulliamy, T; + view all
(2016)
DNAJC21 Mutations Link a Cancer-Prone Bone Marrow Failure Syndrome to Corruption in 60S Ribosome Subunit Maturation.
American Journal of Human Genetics
, 99
(1)
pp. 115-124.
10.1016/j.ajhg.2016.05.002.
|
|
U
|
UK CLL Forum;
(2016)
Ibrutinib for relapsed/refractory chronic lymphocytic leukemia: a UK and Ireland analysis of outcomes in 315 patients.
Haematologica
, 101
(12)
pp. 1563-1572.
10.3324/haematol.2016.147900.
|
|
|
Underwood, M;
Peyvandi, F;
Garagiola, I;
Machin, S;
Mackie, I;
(2016)
Degradation of two novel congenital TTP ADAMTS13 mutants by the cell proteasome prevents ADAMTS13 secretion.
Thrombosis Research
, 147
pp. 16-23.
10.1016/j.thromres.2016.09.014.
|
|
Uuskula-Reimand, L;
Hou, H;
Samavarchi-Tehrani, P;
Rudan, MV;
Liang, M;
Medina-Rivera, A;
Mohammed, H;
... Wilson, MD; + view all
(2016)
Topoisomerase II beta interacts with cohesin and CTCF at topological domain borders.
Genome Biology
, 17
, Article 182. 10.1186/s13059-016-1043-8.
|
V
|
Vagaska, B;
New, SP;
Alvarez Gonzalez, C;
D'Acquisto, F;
Gomez, SG;
Bulstrode, NW;
Madrigal, A;
(2016)
MHC-class-II are expressed in a subpopulation of human neural stem cells in vitro in an IFNγ-independent fashion and during development.
Scientific Reports
, 6
, Article 24251. 10.1038/srep24251.
|
|
|
van der Wel, MJ;
Jansen, M;
Vieth, M;
Meijer, SL;
(2016)
What Makes an Expert Barrett's Histopathologist?
STEM CELLS, PRE-NEOPLASIA, AND EARLY CANCER OF THE UPPER GASTROINTESTINAL TRACT
, 908
pp. 137-159.
10.1007/978-3-319-41388-4_8.
|
|
Van Dongen, J;
Nivard, MG;
Willemsen, G;
Hottenga, JJ;
Helmer, Q;
Dolan, CV;
Ehli, EA;
... Boomsma, DI; + view all
(2016)
Genetic and environmental influences interact with age and sex in shaping the human methylome.
Nature Communications
, 7
, Article 11115. 10.1038/ncomms11115.
|
|
|
Vanhaesebroeck, B;
Whitehead, MA;
Pineiro, R;
(2016)
Molecules in medicine mini-review: isoforms of PI3K in biology and disease.
Journal of Molecular Medicine
, 94
(1)
pp. 5-11.
10.1007/s00109-015-1352-5.
|
|
Vassiliou, LV;
Lalabekyan, B;
Jay, A;
Liew, C;
Whelan, J;
Newman, L;
Kalavrezos, N;
(2016)
Head and neck sarcomas: A single institute series.
Oral Oncology
, 65
pp. 16-22.
10.1016/j.oraloncology.2016.12.005.
|
|
Vena, F;
(2016)
MEK inhibition in pancreas cancer.
Doctoral thesis , UCL (University College London).
|
|
|
Vindrola-Padros, C;
Taylor, RM;
Lea, S;
Hooker, L;
Pearce, S;
Whelan, J;
Gibson, F;
(2016)
Mapping Adolescent Cancer Services: How Do Young People, Their Families, and Staff Describe Specialized Cancer Care in England?
Cancer Nursing
, 39
(5)
pp. 358-366.
10.1097/NCC.0000000000000315.
|
W
|
Wardle, J;
von Wagner, C;
Kralj-Hans, I;
Halloran, SP;
Smith, SG;
McGregor, LM;
Vart, G;
... Raine, R; + view all
(2016)
Effects of evidence-based strategies to reduce the socioeconomic gradient of uptake in the English NHS Bowel Cancer Screening Programme (ASCEND): four cluster-randomised controlled trials.
The Lancet
, 387
(10020)
pp. 751-759.
10.1016/S0140-6736(15)01154-X.
|
|
Weitsman, G;
Barber, PR;
Nguyen, LK;
Lawler, K;
Patel, G;
Woodman, N;
Kelleher, MT;
... Ng, T; + view all
(2016)
HER2-HER3 dimer quantification by FLIM-FRET predicts breast cancer metastatic relapse independently of HER2 IHC status.
Oncotarget
, 7
(32)
pp. 51012-51026.
10.18632/oncotarget.9963.
|
|
Westmoreland, D;
Shaw, M;
Grimes, W;
Metcalf, DJ;
Burden, JJ;
Gomez, K;
Knight, AE;
(2016)
Super-resolution microscopy as a potential approach to platelet granule disorder diagnosis.
Journal of Thrombosis and Haemostasis
, 14
(4)
10.1111/jth.13269.
|
|
Wheeler, GM;
(2016)
Incoherent dose-escalation in phase I trials using the escalation with overdose control approach.
Statistical Papers
pp. 1-11.
10.1007/s00362-016-0790-7.
|
|
Wheeler, GM;
Sweeting, MJ;
Mander, AP;
(2016)
AplusB: A Web Application for Investigating A plus B Designs for Phase I Cancer Clinical Trials.
PLOS ONE
, 11
(7)
, Article e0159026. 10.1371/journal.pone.0159026.
|
|
|
Wulaningsih, W;
Holmberg, L;
Abeler-Doner, L;
Ng, T;
Rohrmann, S;
Van Hemelrijck, M;
(2016)
Associations of C-Reactive Protein, Granulocytes and Granulocyte-to-Lymphocyte Ratio with Mortality from Breast Cancer in Non-Institutionalized American Women.
PLoS ONE
, 11
(6)
, Article e0157482. 10.1371/journal.pone.0157482.
|
|
|
Wulaningsih, W;
Holmberg, L;
Garmo, H;
Karagiannis, SN;
Ahlstedt, S;
Malmstrom, H;
Lambe, M;
... Van Hemelrijck, M; + view all
(2016)
Investigating the association between allergen-specific immunoglobulin E, cancer risk and survival.
Oncoimmunology
, 5
(6)
, Article e1154250. 10.1080/2162402X.2016.1154250.
|
|
Y
|
Yang, Z;
Wong, A;
Kuh, D;
Paul, DS;
Rakyan, VK;
Leslie, RD;
Zheng, SC;
... Teschendorff, AE; + view all
(2016)
Correlation of an epigenetic mitotic clock with cancer risk.
GENOME BIOLOGY
, 17
(ARTN 205)
10.1186/s13059-016-1064-3.
|
|
|
Yong, K;
Cavet, J;
Johnson, P;
Morgan, G;
Williams, C;
Nakashima, D;
Akinaga, S;
... Cavenagh, J; + view all
(2016)
Phase I study of KW-2478, a novel Hsp90 inhibitor, in patients with B-cell malignancies.
British Journal of Cancer
, 114
(1)
pp. 7-13.
10.1038/bjc.2015.422.
|
|
Yong, K;
Delforge, M;
Driessen, C;
Fink, L;
Flinois, A;
Gonzalez-McQuire, S;
Karlin, L;
... Cavo, M; + view all
(2016)
Multiple myeloma: patient outcomes in real-world practice.
British Journal of Haematology
, 175
(2)
pp. 252-264.
10.1111/bjh.14213.
|
|
|
Young, LC;
(2016)
Regulation of the RAS-ERK pathway by SHOC2.
Doctoral thesis , UCL (University College London).
|
|
Youssef, G;
(2016)
Mechanisms of Hyperkeratosis in Autosomal Recessive Congenital Ichthyosis (ARCI).
Doctoral thesis , UCL (University College London).
|
|
Yuan, Z;
Lourenco, SDS;
Sage, EK;
Kolluri, KK;
Lowdell, MW;
Janes, SM;
(2016)
Cryopreservation of human mesenchymal stromal cells expressing TRAIL for human anti-cancer therapy.
Cytotherapy
, 18
(7)
pp. 860-869.
10.1016/j.jcyt.2016.04.005.
|
|
Z
|
Zamborszky, J;
Szikriszt, B;
Gervai, JZ;
Pipek, O;
Poti, A;
Krzystanek, M;
Ribli, D;
... Szuets, D; + view all
(2016)
Loss of BRCA1 or BRCA2 markedly increases the rate of base substitution mutagenesis and has distinct effects on genomic deletions.
Oncogene
, 36
(6)
pp. 746-755.
10.1038/onc.2016.243.
|
|
|
Zhang, J;
Riby, JE;
Conde, L;
Grizzle, WE;
Cui, X;
Skibola, CF;
(2016)
A Fucus vesiculosus extract inhibits estrogen receptor activation and induces cell death in female cancer cell lines.
BMC Complement Altern Med
, 16
p. 151.
10.1186/s12906-016-1129-6.
|
|
Zhang, R;
Fruhwirth, GO;
Coban, O;
Barrett, JE;
Burgoyne, T;
Lee, SH;
Simonson, PD;
... Selvin, PR; + view all
(2016)
Probing the Heterogeneity of Protein Kinase Activation in Cells by Super-Resolution Microscopy.
ACS Nano
, 11
(1)
pp. 249-257.
10.1021/acsnano.6b05356.
|
|
Zhou, L;
Lyons-Rimmer, J;
Ammoun, S;
Müller, J;
Lasonder, E;
Sharma, V;
Ercolano, E;
... Hanemann, CO; + view all
(2016)
The scaffold protein KSR1, a novel therapeutic target for the treatment of Merlin-deficient tumors.
Oncogene
, 35
pp. 3443-3453.
10.1038/onc.2015.404.
|
|
|
Zinngrebe, J;
Rieser, E;
Taraborrelli, L;
Peltzer, N;
Hartwig, T;
Ren, H;
Kovacs, I;
... Walczak, H; + view all
(2016)
LUBAC deficiency perturbs TLR3 signaling to cause immunodeficiency and autoinflammation.
Journal of Experimental Medicine
, 213
(12)
pp. 2671-2689.
10.1084/jem.20160041.
|
|
Zubairi, I;
Dean, E;
Molife, LR;
Lopez, J;
Ranson, M;
El-Khouly, F;
Savulsky, C;
... Evans, TRJ; + view all
(2016)
Phase 1 multicenter, open-label study to establish the maximum tolerated dose (MTD) of two administration schedules of E7389 (eribulin) liposomal formulation in patients (pts) with solid tumors.
Presented at: 2016 Jahrestagung der DGHO, OeGHO, SGMO und SGH, Leipzig, Germany.
|
